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A BSTRACT

The stability of a protein-based biological drug is an important concern during
processing, storage or patient administration. There are various forces which contribute to
the stabilizing of proteins. Both hydrogen bonds and hydrophobic interactions play an
important role in protein stability. Improper folding or misfolding of proteins leads to
aggregation, which is a major problem found in the bioprocessing industry. The objectives
of this research are: 1) to determine the effect of environmental factors such as pH,
temperature, additives or salts, and cosolvents on the stability human serum albumin
(HAS), which is the most abundant protein in plasma, 2) to determine the effect of
environmental factors on the propensity to aggregate of insulin fragments,

and 3) to

determine the effect of post-translational modifications such as glycosylation on the
propensity to aggregate of insulin fragments.

Small-Angle Neutron Scattering (SANS)

was used to explore the effect of environmental factors on the intra and inter molecular
interactions of HSA. The effect o f cosolvents, pH and temperature on the protein
conformation and on protein-protein interactions was explored. The propensity to
aggregate, particularly the propensity to form amyloid fibrils of the region of the insulin
A-chain (where amino acid sequence for bovine and human insulins is different) was then
studied. Aggregation was monitored by fluorescence and infrared spectroscopy and optical
microscopy. Both fragments formed fibrils at pH 1.6 and a temperature of 60°C. These
peptides were glycosylated with D-glucose by the Maillard reaction to increase their
stability. Glycosylated peptides were highly stable and they did not show signs of fibril
formation during the course of the experiment.
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1. INTRODUCTION

Proteins and peptides are important for life as we know it. They serve as catalysts
for the biochemical reactions that take place inside cells, they transport materials from
place to place, they play key functions in our immune system, they serve as signal
transmitters, etc. Amino acids are the building blocks of proteins and peptides. Long chains
of amino acids make proteins whereas shorter ones make peptides. Proteins have four
levels of organization: primary, secondary, tertiary and quaternary structure. While primary
structure is simply the sequence of amino acids in a polypeptide chain, secondary structure
refers to the local folded structures that form within a protein. The three-dimensional shape
of the protein is its tertiary structure and the number and arrangement of multiple folded
subunit complexes is the quaternary structure of a protein.
Biopharmaceutical companies invest a large portion of their resources to generate
libraries of protein therapeutics. The stability of a protein is an important concern during
expression, purification, formulation and storage of these proteins [1]. The consequences
of lack of stability (on the shelf) of a biologic can be devastating for the patient whereas
the lack of stability during processing results in financial loses. Stability manifests in two
different dimensions: a) within each molecule (intramolecular) it is associated with the
ability to maintain the three-dimensional shape that the protein needs to perform its
biological functions and b) in between molecules (intermolecular) it is associated with the
lack of formation of aggregates.
The intramolecular protein stability is the result of the net balance of forces, which
determines whether a protein will be in its native folded conformation or in a denatured
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state [2]. There are various forces that contribute to stabilize proteins [3]. Both hydrogen
bonds and hydrophobic interactions play an important role in protein stability. Each
hydrogen bond upon folding contributes 1.1±0.8 Kcal/mol to protein stability. An average
of 85% of the nonpolar side chains bury to form 1.1 hydrogen bonds per residue, which
contributes to proper protein folding [4,5]. Also, buried polar groups that are not hydrogen
bonded can contribute to protein stability. Other forces which contribute to protein stability
are disulfide bonds. For example, addition of 3 disulfide bonds increases the melting
temperature of T4 lysozyme by 23.4°C [6].
Protein folding results in the release of the water that is hydrogen-bonded to the
polypeptide chain. That release increases the configurational entropy of water and thus
stabilizes the folded structure. Under physiological conditions in an aqueous solution, a
protein folds into a-helices, turns or P-sheets depending upon its primary structure [3]. A
typical change in the free energy of 5-15 Kcal/mol between the folded and unfolded
structures is observed in most proteins.
The intermolecular stability is controlled by electrostatic, hydration and
hydrophobic forces. Electrostatic forces are long-range forces that originate on direct
Coulombic as well as dipole-dipole and induced dipole-induced dipole interactions. They
weaken as the ionic strength of the solution or the dielectric constant of the solvent
increases. Coulombic forces maybe attractive or repulsive whereas dipole-dipole and
induced dipole forces are always attractive. Hydration forces are strong and short-range
repulsive forces between charged or polar surfaced molecules separated by a thin water
layer. Hydrophobic forces are attractive forces between two non-polar surfaces.
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Proteins in solution may be de-stabilized to different extents. The repulsive forces
that keep the proteins in solution may be weakened by external factors causing the proteins
to aggregate and precipitate. The de-stabilizing agent may be a change in pH, a change in
the polar characteristic of the solvent, or the addition of salts or polymers [7]. A change in
pH, temperature or solvent polarity may also induce a disruption in tertiary or secondary
structure of the protein [8]. These changes in the conformation of the protein may lead to
precipitation but also the denatured protein may remain in solution [9]. These two different
levels of perturbations to a protein solution may lead to the formation of aggregates that
will eventually form a precipitate. The protein in these aggregates may be native or may
be completely or partially denatured. Our attention has been focused on the effect of the
polarity of the solvent, pH, temperature, addition of denaturants, and stirring on protein
stability [10]. The effects of these parameters are explained in the following paragraphs.
The effect of the polarity of a solvent or its capability to participate in hydrogen
bonds on protein stability is significant. The folded structure of a protein is marginally
stable and, therefore, the folding/unfolding equilibrium of proteins in aqueous solution can
shift either way upon addition of cosolvents. While methanol cannot substitute the essential
water from the protein hydration layer, glycerol can induce protein preferential hydration
particularly at hydrophobic patches [11]. Studies show that the interaction of water with
cosolvents like trimethylamine N-oxide (TMAO) plays an important role in determining
the preferential exclusion from protein surfaces [12]. Ionic liquids are also important in the
preservation of protein [13]. Ionic liquids are salts consisting of poorly coordinated ions,
which remain in liquid state at temperatures < 100°C. Because of their unusual properties
like low melting point, low vapor pressure, low toxicity as well as high polarity and thermal
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stability they are considered as ‘ green solvents’ [14]. For example, lysozyme is stable in
a solution of ionic liquids containing [emim]+ cations and other anions [15].
Temperature affects protein stability. Incubating protein solutions at high
temperatures can cause changes in the tertiary structure, which can lead to irreversible
aggregation [16]. It is well known that the aggregation happens well below the equilibrium
melting temperature of a protein which infers that it is not the fully unfolded proteins which
aggregate but rather partially unfolded molecules [17]. O f course, denaturants like urea and
guanidine chloride will affect the stability of the protein. Interfaces like solid/liquid or
gas/liquid can also induce partial unfolding and thus protein aggregation. Stirring
incorporates air into the solution creating a gas/liquid interface, which can affect stability.
Ionic strength and pH affect Coulombic interactions between the side chains of
amino acids and that affects protein stability. They also affect intra and inter dipole-dipole
and induced dipole-induced dipole interactions. Moreover, charge-charge interactions and
salt bridges contribute to protein stability. Salt bridges are oppositely charged groups
within 5A distance in the proteins. A salt bridge on the surface contributes to < 1 Kcal/mol
to the stability while a buried salt bridge can contribute to more than 4 Kcal/mol to the free
energy of folding [18,19]. Finally, the degree o f ionization of different groups on the
protein’s surface depends on the pH and on ionic strength. The degree of ionization of the
surface group determines the protein net charge, which defines the range and strength of
Coulombic repulsions. That electrostatic repulsive force between protein molecules is the
prevailing force preventing protein aggregation.
As we explained above, the de-stabilization of a protein in solution may lead to the
formation of aggregates. Aggregates may be disordered or ordered; amyloid fibrils are one
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type of ordered aggregates. They are P-sheet rich linear aggregates formed from circular
oligomers. X-Ray diffraction of amyloid fibrils shows a cross-P diffraction pattern which
is a trademark of intermolecular P-sheet structures [20-23]. This intermolecular P-sheet
structure is easily identified also by FTIR. It has been recently proven that oligomers are
the elemental blocks to build a fibril [24,25]. The propensity to form amyloid fibrils seems
to be correlated with the hydrophobicity of proteins [26]. Amyloid fibrils are a unique type
of ordered aggregates formed by different proteins and peptides in vivo as well as in vitro.
Formation of amyloid fibrils is associated with various neurodegenerative diseases like
Alzheimer’s, Parkinson’s and Huntington’s disease [27]. Although amyloid fibrils are
mostly related to disease causing proteins, it was also reported that if appropriate
incubation conditions were provided even a non-pathogenic protein can form a fibrillar
structure [28]. Amyloid aggregates can also be used as scaffolds, as peptide hormones
storage and natural adhesives [29]. Fibrils can also be synthesized in vitro by subjecting
the protein to favorable destabilizing conditions [30,31]. For example, hen lysozyme
incubated at pH 2.0 and 37°C forms fibrils [32].
Post-translational modification of a protein affects both its biological activity and
stability. There are different types of post translational modifications that occur at a cellular
level. Most common among them are phosphorylation, glycosylation, lipodation,
methylation and acetylation. Changes in the glycosylation pattern is one approach to
change the stability of a protein therapeutic. Glycosylation consists of the addition of
various sugars to the polypeptide chain [33,34]. There is no consensus about the role played
by glycosylation on protein stability. It has been argued that protein glycosylation protects
against proteolytic degradation,

oxidation,

chemical

cross linking, precipitation,
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aggregation, kinetic deactivation, and denaturation induced by changes in pH, addition of
denaturants, and high and low temperatures. A better understanding of the role of
glycosylation on protein stability will facilitate the engineering of proteins/ peptides with
a glycosylation pattern that increases their shelf-life, minimizes losses during processing
but does not alter the potency of the protein therapeutics nor changes its allergenic
properties.
Glycosylation happens in vitro via two linkages i.e., via N-linkage known as Nglycosylation and via O-linkage known as O-glycosylation. Amino acids like serine,
glutamine, lysine can undergo glycosylation. Protein/peptide glycosylation can be N-type
or O-type depending upon the type of amino acid and its availability whether it is on the
surface or buried inside the polypeptide chain. Glycopeptides can be synthesized either by
direct incorporation of a glyco amino acid during peptide synthesis or by heavily
glycosylating the peptide with a known sugar following the Maillard reaction [35]. Direct
incorporation of sugars during the peptide synthesis can lead to a controlled reaction where
the number of carbohydrate moieties being attached can be monitored. The main challenge
lies in synthesizing the glycoamino acids to be used for peptide synthesis. Synthesizing
glyco amino acids is quite expensive as opposed to the direct glycosylation of a peptide.
Synthesis of glyco amino acids typically takes place in organic solvents like DCM
(Dichloro Methane). The challenge is to remove the organic solvent from the synthesized
glyco amino acid [36]. A rotary evaporator which is typically used to remove solvents is
not effective in this case (unpublished data).
The main objective of this dissertation was to study the stability of plasma proteins
and their fragments. This dissertation is a humble effort to augment our knowledge of
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protein stability.

My studies ranged from experiments probing molecular level

phenomena to experiments at the macroscopic scale. This dissertation is divided into three
parts that are briefly described below.
In Paper I, the effect o f cosolvents, pH and temperature on the structure and
stabilizing forces for human serum albumin (HSA) using small angle neutron scattering
(SANS) was explored. The experimental data for this project was provided by Dr. Daniel
Forciniti who conducted the SANS experiments at Oak Ridge National laboratory, TN.
We explored intra and intermolecular interactions between protein molecules. The results
of this work help to better understand the aggregation process. The interaction potential
that can be extracted from SANS data offers an insight into the type and strength of the
intermolecular interactions in solution. In the absence of intermolecular interactions, the
shape of HSA changed from a prolate to an oblate ellipsoid as the concentration increased.
Methanol increases the disorder of a solution of HSA whereas glycerol makes the solution
more structured.
In Paper II, we studied the amyloidogenic regions of insulin from different species
at various conditions using a screening experimental design in order to determine the
favorable conditions for fibrillation. The studies were focused on short peptides having
well-defined secondary structures, which mimic protein domains. The study of individual
domains seems to be a logical approach towards the understanding of proteins responses
to stresses and how that response may be affected by the presence of the stabilization
groups. Peptides were synthesized using an F-moc chemistry in a solid phase peptide
synthesizer. Mass and NMR spectroscopies were used to identify the synthesized products
and to quantify them. A fluorometric assay was used to monitor the progress of fibrillation.
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Fourier Transform Infra-Red (FTIR) spectroscopy was used to monitor the secondary
structural changes in the peptides. A digital microscope is used to obtain visual evidence
of the fibrils. The effects of temperature, urea, ionic strength, pH and stirring on the
fibrillation process were explored. It was found that the bovine insulin fragments aggregate
faster than the human fragments. Both the fragments showed an increase in the P-sheets
content with time.
In Paper III, the peptides used in Paper II were glycosylated to study the effect of
that post-translation modification on their ability to form amyloid fibrils. Insulin A-chain
fragments from bovine and human species were glycosylated using a-D-Glucose.
Experiments were performed at pH 1.6 and 60°C under stirring conditions in the presence
of 1M urea and 20 mM NaCl. Aggregation was monitored using a fluorescent assay as
well as by turbidity. The aggregates were characterized using FTIR and Congo red staining.
The glycosylated peptides did not show any signs of fibril formation. The turbidity assay
revealed the underlying oligomer formation mechanism, which is not seen using a
fluorescent assay.
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PA PE R

I. E F F E C T O F M ETH A N O L AND G LY C ER O L ON TH E STRUCTURE OF
HUM AN SERUM ALBUM IN SOLUTIONS

A BSTRACT

Small angle scattering (SAS) is an important tool to study the structural properties
and interactions of biological macromolecules. Numerous studies have been published
about the effect of organic solvents on intramolecular protein interactions. However, little
attention has been paid to the effect o f organic solvents on both intra and inter molecular
interactions in protein solutions. The solution behavior of human serum albumin (HSA) in
the presence of methanol and glycerol was studied by small angle neutron scattering
(SANS). The experiments covered a wide range of protein, salt, and cosolvent
concentrations at 5, 25, and 45 °C. UV and infrared spectra of selected samples were also
obtained to monitor protein denaturation upon addition of the cosolvents. An ellipsoid form
factor in combination with Hayter-Penfold rescaled mean spherical approximation were
used to fit the data at high protein concentrations. The overall dimensions of HSA obtained
in this work are consistent with previously reported data. Pairwise distribution function
(P(r)) profiles were used to deduce the particle shape using GNOM. With an increase in
the concentration of protein, HSA changes from a prolate to an oblate ellipsoid form. It
was observed that methanol makes the interaction potential more attractive whereas
glycerol makes it more repulsive.
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1. IN TRO D U C TIO N

The distribution of proteins in a solvent depends not only on direct interactions
between proteins but also on solvent-mediated forces. The former depends on the chemical
structure of the protein and on the dielectric constant of the solvent (s), whereas the latter
depends on the chemical nature of both the protein and the solvent. Two solvent-related
forces that affect protein structure and protein-protein interactions are hydrophobic
attraction and hydrophobic hydration (repulsive). As two nonpolar molecules (or two
hydrophobic portions of the same molecule) approach one another they push ordered water
molecules into the bulk causing an increase in entropy. Conversely, we can argue that
increase in entropy causes an attraction between hydrophobic surfaces (hydrophobic
attraction). These forces affect the folding of the molecule and may induce protein
aggregation [1]. Protein molecules in solution are surrounded by a layer of water molecules
attached to the protein surface mainly by hydrogen bonds. The addition of an organic
solvent distorts this layer of water and as a result the protein may denature [2]. On the
contrary, solvents that promote the stabilization of the hydrogen-bonded network of liquid
water will stabilize the water layer increasing the repulsion between proteins (hydrophobic
hydration) [2]. Other additives, like salts or nonionic polymers, also affect intermolecular
forces [3,4]. To understand the effect of water on the 3D shape of proteins in solution,
researchers have looked up the effect that partial replacement of water by other solvents
has on a protein 3D organization. The addition of a cosolvent stabilizes or destabilizes a
protein structure depending on the difference between the preferential interaction of the
mixed solvent with the protein in the unfolded and native states [5,6].
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Gupta et al., [7] examined the effect that various organic solvents have on several
proteins and concluded that methanol cannot substitute “essential” water from the protein
hydration layer whereas glycerol can. Thus, these two solvents not only alter electrostatic
interactions by decreasing the dielectric constant o f the solvent (smethanol= 32.7 and Sglycerol=
42.5, Swater= 78), but also change the solution behavior of the protein by changing its
interactions with the solvent. Studies of protein solutions in which part of the water is
replaced by methanol or glycerol provide an insight into the relative importance of solventmediated forces and therefore, they constitute an astringent test for mean field
approximations.

Glycerol

induces

protein

preferential

hydration

particularly

at

hydrophobic patches, increases the solubility of proteins, and reduces the protein’s surface
area since the protein adopts a more compact conformation to compensate for the increase
in chemical potential [7-9]. A mono alcohol (such as methanol) can participate in limited
hydrogen bonding. Therefore, a mixture of water and alcohol will exhibit a hydrogen
bonding network that will be different from that of pure water. Methanol is used to
precipitate proteins and it is a well-known denaturant at considerable high concentrations.
The addition of methanol, a less polar (dipolar moment = 1.70 Debye, s = 32.7) solvent
than water (dipolar moment = 1.85 Debye, s = 78.54) most likely displaces water from
hydrophobic patches disrupting the clathrate structure and decreasing the hydration
repulsion and perhaps increasing the hydrophobic attraction. [10].
The effect of cosolvents on intra and intermolecular structure was studied using
SANS. The general approach to interpret SANS data is as follows. The experimental data
obtained under conditions where intermolecular interactions can be neglected (low protein
concentrations, high ionic strength), is fitted using a model for the intramolecular structure
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factor. Then, the intermolecular structure factor is calculated using, for example, an
appropriate closure for the Ornstein Zernike equation like the Percus-Yevick or mean
spherical approximations with a intermolecular potential that captures the main
intermolecular forces [11]. The intra and intermolecular structure factors are combined and
used to fit SANS data at all protein concentrations and solvent conditions.
Human Serum Albumin (HSA) was chosen in this work because it is the most
abundant and better-known plasma protein. Its molecular weight is 66,248 Da and its
isoelectric point is 4.7. A detailed crystallographic structure of HSA has been determined
[12,13]. The molecule has a heart shape that can be approximated by a solid equilateral
triangle with sides of 80 A and depth of 30 A. HSA consists of three well-defined domains.
Two of them (I and II) form the wider portion of the heart whereas the third one (III) forms
its tip. Domain III is positively charged at physiological pHs. HSA is a very stable protein.
Changes in the conformation of this protein upon changes in pH have been observed in
proteins from several species including bovine and human. However, changes in the overall
size have not been detected using low resolution techniques such as photon correlation
spectroscopy in the pH range from 5 to 10 [14].
The dependence of protein structure and protein-protein interactions on pH, salt and
protein concentrations has been studied [15,16]. Unfortunately, those studies offer limited
information since by manipulating those variables researchers have failed to explore the
effect of the chemical nature of the solvent. Therefore, solvent-mediated phenomena may
have been overlooked and their effects inadvertently included into the model parameters.
New information can be obtained by studying the behavior of proteins in mixtures of
methanol, glycerol and water at different temperatures. These two solvents have different
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effects on the structure and solution behavior of proteins. The effect of temperature,
although it may be small, can be used to discriminate between different hypothesis.
Here, first we present and analyze experimental data obtained under conditions
where intermolecular interactions are minimized. This is done using Guinier analysis, P(r)
analysis and fitting the data using an ellipsoid model in Igor PRO. Pairwise distribution
function (P(r)) profiles were used to deduce the particle shape using GNOM [17]. After
that, we present and discuss experimental results where intermolecular interactions
dominate the structure of the solution. Intermolecular interactions can be captured by
combining the form factor with a suitable interparticle structure factor.

2. EX PER IM EN TA L SECTIO N

2.1. M A TER IA LS AND M ETH O D S
Essentially fatty acid free HSA was bought from Sigma and used as received. Fully
deuterated solvents were from Sigma (St. Louis, MO). HSA solutions at various
concentrations were made ready by dissolving the protein in binary mixtures of fully
deuterated methanol or glycerol with deuterium oxide in 20 mM phosphate buffer. The pH
was adjusted to 6. Insoluble matter was removed by centrifuging and the concentration of
protein in the sample was measured spectrophotometrically at 280 nm (s = 0.531 L/g cm).
A wavelength scan was done for each sample from 350 nm to 270 nm. Negligible
adsorption at 350 nm was taken as an indication of completely transparent samples. In the
few cases where the absorption at 350 nm was not negligible the absorbance at 350nm was
extrapolated to 280nm and the value subtracted from the sample. This correction was
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always smaller than 5%. The samples were run at three different temperatures, 5, 25 and
45 0C.
Ultraviolet and infrared spectroscopy were used to determine the stability of HSA
in mixtures of methanol and water. UV spectra were measured in a Shimadzu
spectrophotometer using a protein concentration of 3 mg/ml. Appropriate blanks were
discounted before calculating the second derivative spectra. Fourier Transform infrared
spectroscopy was done using a Nicolet 6700 spectrophotometer. The protein solution
(approximately 10 mg/ml) was placed in a CaCh cell (0.1 mm path length). After 15
minutes stabilization, the samples were scanned 400 times. Background spectra of the
solvents blank (either water or methanol/water mixtures) were subtracted from each sample
spectra. Amide I band of each spectrum was Fourier self-deconvoluted to resolve peaks
that provide information about secondary structure.
Neutron scattering experiments were conducted at the 30m SANS instrument at the
High Flux Isotope Reactor (HFIR) within the national center for small angle scattering
research at Oak Ridge National Laboratory. The protein solutions were placed in flat
cylindrical quartz cells having 1 mm thick circular windows and a path length of 1- or 2
mm. Multiple samples were mounted on an automatic rotating sample exchanger
maintained at constant temperature by circulating water. To prevent the deuterated water
from becoming contaminated with atmospheric moisture, all SANS samples remained
sealed throughout the experiments.
The experiments were performed on the W. C. Koehler 30m SANS facility at the
Oak Ridge National Laboratory. The neutron wavelength was 0.475 nm (Dl/l= ±5%) and
the source (3.5 cm in diameter) and sample (1.0 cm in diameter) slits (irises) were separated
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by 7.5 m. The sample-detector distance was either 13.5 or 2.49 m and the data were
corrected for instrumental backgrounds and detector efficiency on a cell-by-cell basis
before radial averaging to give a momentum transfer (Q) range of 0.05 < Q < 2.5 nm-1. The
coherent intensities of the sample were obtained by subtracting the intensities of the
corresponding blanks (either heavy water or the appropriate heavy water/organic solvent
mixture), which formed only a minor correction (<10%) to the sample data. The net
intensities were converted to an absolute (±5%) differential cross section per unit sample
volume (in units of cm-1) by comparison with pre-calibrated secondary standards, based on
the measurement of beam flux, vanadium incoherent cross section, the scattering from
water and other reference materials. The efficient calibration was based on the scattering
from light water and this led to angle-independent scattering for vanadium, H-polymer
blanks and water samples of different thickness in the range 1-10 mm.
The transmission of the sample was measured in a separate experiment by
collimating the beam with slits (irises) approximately 1 cm in diameter, separated by 7.5
m. A strongly scattering sample, porous carbon, was placed at the sample position to spread
the beam over the whole detector, placed at a sample-detector distance of 10 m. Without
the carbon in position, the beam would either be blocked by the beam stop or concentrated
in a few detector cells, with the possibility of saturating or damaging the detector. The total
count summed over the whole detector (>105) was recorded for ~1 minute and the sample
being measured was placed over the slit, thus attenuating the beam. The count was repeated
over the same time interval and the transmission is given by the ratio of the two counts
after minor corrections (< 0.1%) for the beam-blocked background due to electronic noise,
cosmic rays, etc. In this geometry only scattering from the sample at Q-values < 10-2 nm-1
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can enter the second iris and be scattered by the porous carbon and hence be counted by
the detector.

2.2. DATA ANALYSIS
The analysis of SANS data is well documented in the literature [18]. The intensity
(I(Q)) of the scattered neutrons in terms of the form factor (F(Q)) and intermolecular (S(Q))
structure factor is given by:

I ( Q)

cNa ( vMY
< F (Q )2 > A p 2
M VNa J

O+

( < F ( Q ) >2’

[S ( Q) -1 ] -

(1)

V< F ( Q )2 >J

where c is the concentration of the protein in g/cm3, Na is the Avogadro’s number, M is
the protein’s molecular weight, v is protein’s specific volume in cm 3 /g, and Ap is the
difference between the scattering density of the scatters, pp and the scattering density of
the solvent, ps, in cm-2. The brackets indicate angular averages.
The form factor can be calculated from the crystal structure of the protein, by
modeling the proteins as an assembly of spheres or by assuming a shape for the protein
molecule [19]. Calculations based on the crystal structure are formally exact but highly
complex. The use of an assembly of spheres model is attractive but also quite complex and
the structure obtained may not be unique. Finally, calculations based on the assumption of
a simple form for the protein molecule (ellipsoids, spheres, or cylinders) are
computationally simpler but less precise. This simple approach yields excellent fittings and
it is computationally cheap. The interparticle structure factor, S(Q), was calculated using a

17
simple approach by assuming the particles to be charged and spherical in a dielectric
medium using Hayter- Penfold rescaled MSA [20-22].
To interpret SANS data correctly changes in intramolecular structure must be
identified and quantified before intermolecular interactions can be studied. To be able to
extract information about the effect of the added cosolvents on the structure of protein
solutions, one needs to rule out or account for major changes in protein conformation or
aggregation induced by the addition of the solvents. One way of obtaining information
about size changes and to detect the presence of aggregates is to perform a Guinier analysis
of the data.
A plot of ln(I(Q)) vs. Q 2 yields a straight line whose slope is proportional to the
radius of gyration of the scatters and whose intercept is proportional to their molecular
weight,

2

I (0)

cNa f vM''
Ap2
M V Na

(2 )

The approximations that lead to Guinier analysis are valid in the low Q region when
using dilute protein solutions in the presence of high concentrations of salt. The addition
of NaCl or other salts is necessary since otherwise the analysis cannot be performed
because of the presence of a first correlation peak in the spectrum (a result of interference
between waves scattered by more than one protein molecule). The data, however, must be
analyzed with caution since extrapolation at other conditions is not always valid. For
example, aggregation may not occur under conditions in which Guinier analysis is valid
(absence of intermolecular interaction, low Q values) but occurs in more concentrated

18
solutions, even in the absence of NaCl. Similarly, aggregation may occur in the presence
of NaCl but not in its absence.
Data analysis was performed using Igor Pro (v 8.02; waveMetrics, Lake Oswego,
OR, USA) using the algorithms based on NCNR analysis package [23]. The particle
distance distribution function P(r) determination was done using a program suite ATSAS
2.8.4 [24]. The inverse transformation of I(Q) allows for the calculation of P(r) given by

00
r
P(r) =
I QI(Q) sin(Qr) dQ
2n2 Jn
p

(3)

The dielectric constant for the binary solvent mixture with respect to solvent composition
(0) and temperature (T) is calculated using the following equation.

ln £m = 0! ln £i + 02 ln £2 + 0102
jI= 0f L

where Sm, S1 ,

82

(4)

1 - 02)
T

corresponds to the dielectric constants of mixture and solvents

1

and

2

respectively. Aj corresponds to the constants for the specific binary system obtained from
literature [25-27]. The values of the dielectric constants of the three solvents at 5, 25, and
40 oC are summarized in Table 1.
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Table 1. Dielectric constants of the solvents

Solvent

Temperature (°C)

Sm

D2O

5

85.7

25

78

45

71.5

5

36.4

25

33.1

45

28.4

5

44.2

25

42.5

45

37.3

Methanol

Glycerol

3. RESU LTS AND DISCUSSION

It can be argued that upon addition of methanol the conformation of the protein
changes and that those changes are not captured by SANS [28]. To evaluate these possible
changes, we conducted infrared and UV spectroscopy experiments of selected samples.
Figures 1 and 2 show the UV second derivative spectra for buffer and 30% methanol at
45°C and the Fourier self-deconvoluted spectra (amide I band in the wave number range
1700- 1600 cm-1) of buffer and HSA solutions at 30% methanol concentration and 40%
methanol concentration respectively.
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Figure 1. UV second derivative spectra for HSA solutions
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Up to 30% methanol at room temperature, the IR spectra do not show any
significant change. However, at a concentration of methanol of 40% there is a decrease in
the peak area at 1677 cm -1 relative to the area of the peak at 1654 cm -1 (a-helix). This
indicates a change in the conformation of the protein at these methanol concentrations [29].
In addition to this, there is a shift in the amide II peak to lower frequencies, which is
associated with the degree of hydrogen-deuterium exchange. The presence of methanol in
the medium may facilitate this exchange by “opening” the secondary structure of the
protein. At 40% methanol, we also observed a peak at 1900 cm -1 that is not present at the
other methanol concentrations. This peak may be due to proline chains that become
exposed to the solvent. The addition of up to 30% methanol at room temperature to an HSA
solution does not produce any change in its second derivative spectra (this is not shown
because overlaps perfectly with the spectrum in pure buffer). However, after incubation of
the solution for 30 minutes at 45 0 C we observe the formation of large aggregates. This
solution was filtered through a 0.2 pm filter and the UV spectra were recorded. The
difference in absorbance before the aggregates were formed and after filtration indicates
that approximately 10% (w/w) of the protein is present as large aggregates. The second
derivative spectrum also shows some differences. After heating, there is a decrease in the
intensity in the tryptophan region (291-295 nm) that is due to partial exposure of these
residues to the solvent [30]. Therefore, except at 40% methanol concentrations the protein
is stable at the conditions at which SANS data was obtained. This evidence shows that at
low protein concentrations, HSA remains native when moderate amounts of methanol are
added to a salt-free protein solution. On the contrary, the simultaneous addition of salt and
methanol induce aggregation of the protein at methanol concentrations higher than 15%.
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No apparent change in the shape of the protein upon addition of the cosolvents is
observed at low to ambient temperature. At high temperatures and high methanol
concentrations the protein denatures and form aggregates.
A first set of SANS experiments were performed using low protein concentrations
and relatively high electrolyte (NaCl) concentrations to determine the effect of the
cosolvents on the shape of the protein. Figure 3 shows a representative Guinier plots of
HSA dissolved in D 2 O and D 2 O/ methanol at low protein concentrations. The values of the
radius o f gyration, I(0) and I (0)/cAp2 for various samples are reported in Table 2 together
with 95% confidence intervals.
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We report I(0) and I (0)/cAp2 because I (0)/cAp2 should be a constant for a given
molecular weight and in the absence of intermolecular interactions. Guinier analysis yields
a radius of gyration of 2.6 ± 0.1 nm and an I (0) of 1.01+ 0.04 cm -1 for HSA in pure D 2 O.
The value for the radius of gyration is smaller than the value reported by the SAXS study
of Olivieri and Craivich who reported values for Rg of 3.1 nm at pH 5 and 3.3 nm at pH 7
[31]. Discrepancies between the values of Rg from SANS and SAXS have been explained
by Svergun et al in terms of a hydration shell [32]. The value of the intensity at zero
momentum transfer compares very well with the expected value of 0.96 cm -1 calculated
from Eq. 2. This is a definite evidence that HSA remains monomeric in D 2 O. The increase
in I(0) in

presence of moderate methanol concentrations suggests the formation of

aggregates.

Figure 4. Pair distance distribution functions for HSA at low concentrations
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Table 2. Guinier analysis summary
Solvent

Protein

Radius

Rg from

concentration

of

P(r)

(g/cm 3 )

Gyration

curves

I(0)/cAp 2

I(0)calc

I(0)exp

(cm 6 g " 1 1 0 "
20

^*

(nm)
D2O

0.015

. +0 . 1

2 6

2.7±0.1

6.3±0.2

0.96± 0.05

.

1 01

±0 .

04
D2O+9.3%

0.032

2.3+0.1

2.5±0.1

. ±0 .1

6 8

1.40±0.07

Methanol
D2O+15.5

1.62±0.
01

0.0038

2.9+0.2

3.6±0.5

12.2±0.4

0.16±0.01

%

0.34±0.
01

Methanol
D2O+17.1

0.0060

2.7+0.1

. ±0 .2

2 8

10.7±0.2

%

0.26±0.01

0.47±0.
01

Methanol
* Values for each solvent are calculated according to Eqn 2

This is easily confirmed comparing the calculated values of I(0) with the
experimental ones particularly at methanol concentrations higher that 9.3%. On the other
hand, the variations in Rg under different solvent conditions are not statistically significant
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at 95% confidence. To better understand the effect of the cosolvents and of protein
concentration on the intramolecular structure of HSA, pair distance distribution functions
(P(r)) were calculated at the three protein concentrations used for Guinier analysis. Figure
4 shows the P(r) curves for HSA with increasing concentration that were calculated using
the GNOM program [33]. The maximum diameter of the macromolecule (Dmax) can be
obtained from the P(r) curves (P(r) tends to zero for r>Dmax). The maxima in the peak
corresponds to the most frequently occurring interatomic distances within the structure in
real space.
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HSA at 0.0032 g/cm 3 and 0.0064 g/cm 3 is a prolate ellipsoid whereas at 0.015
g/cm 3 becomes an oblate ellipsoid.34 Proteins tend to evolve into a shape which avoids
random collisions from their sites o f interaction [34]. The values of Rg obtained using P(r)
(also reported in Table 2) are also in good agreement with the values obtained from Guinier
analysis but the observed differences under different solvent conditions are not statistically
significant.
Figure 5 shows a plot of I(Q) vs Q for HSA in D 2 O at 0.3 M NaCl and at three
different concentrations (0.0032 g/cm 3 , 0.0064 g/cm 3 and 0.015 g/ cm 3 ) of the protein along
with its fits. The values of SLD for protein and D 2 O were taken as 3.053 x 10"6 A "2 and
6.335 x

10"6

A "2 . The fits were obtained by assuming the protein to be a prolate ellipsoid at

the two lower concentrations and an oblate ellipsoid at a concentration of 0.015 g/cm 3 . The
minor and major axis are Ra and Rb respectively. This is somehow justified by recent
findings showing that proteins larger than 270 amino acids (HSA has 585 amino acids)
trend to have an ellipsoidal form [26].

Table 3. Using ellipsoids to fit low concentration data
Solvent

Protein Conc (g/cc)

Ra (nm)

D 2 O + 0.3M NaCl

0.0032

13.6±0.2

0.0064
0.015

Rb (nm)

R

1 0

. ±0 .1

2.4±0.1

14.0±0.2

0.9±0.1

2 2

. ±0 .2

4.6±0.2

1 6

1 0

. ±0 .1
. ±0 .2
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The decision to use different shapes was based on the analysis of P(r). Moreover,
Liu et al. measured the distance distribution function for human hemoglobin at different
concentrations which shows that the shape changes with change in protein concentration
[15]. The fitting parameters Ra and Rb are reported in Table 3. The protein becomes more
compact as its concentration increases. The effect of the cosolvents on HSA may be
different in the absence of the salt. To elucidate this point further, we performed a few
experiments using low protein concentrations without added salts. Under these conditions,
the Guinier approximation is not valid but the data can still be analyzed by fitting the
scattering curve in a wider range of momentum transfers using a simple model for the form
factor and the Hayter- Penfold rescaled MSA for the intermolecular structure factor.

Figure 6. Effect of cosolvents on HSA at 0.04 g/cm3 and 25°C
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Table 4. Fitting parameters obtained using HPMSA model

Description

Ra (nm)

Rb (nm)

1 0

. ±0 .1

4.0±0.2

19.3% methanol; 0.04 g/cm3; 25°C

1.4±0.2

23.4% glycerol; 0.04 g/cm3; 25°C

Equivalent
Radius (nm)

Charge

1 6

. ±0 .1

7.2±0.1

4.0±0.2

2.0±0.3

6 6

1 6

. ±0 .1

3.9±0.1

2

.1 ± 0 . 1

7.1±0.1

D2O; 0.14 g/cm3; 25°C

0.7±0.1

4.5±0.1

1.3±0.1

7.8±0.5

19.9% methanol; 0.18 g/cm3; 25°C

1.4±0.1

3.8±0.3

1.9±0.1

6.0±0.5

23.4% glycerol; 0.17 g/cm3; 25°C

1 6

. ±0 .1

3.5±0.1

2

.1 ± 0 . 1

8.6±0.5

D 2 O; 0.30 g/cm3; 5°C

0 6

. ±0 .1

4.0±0.2

1 1

D 2 O; 0.30 g/cm3; 25°C

0 6

. ±0 .1

4.0±0.2

1 1

D 2 O; 0.30 g/cm3; 45°C

0 6

. ±0 .2

4.0±0.2

6.5% methanol; 0.19 g/cm3; 5°C

1.3±0.2

12.8% methanol; 0.18 g/cm3; 5°C

D 2 O; 0.04 g/cm3; 25°C

. ±0 .1

. ±0 .1

. ±0 . 1

10 0

. ±0 .1

9.5±0.1

1 1

. ±0 .1

9.0±0.1

3.8±0.2

1.8±0.3

7.4±0.5

1.3±0.1

3.8±0.1

1 8

. ±0 .1

6.7±0.5

19.9% methanol; 0.18 g/cm3; 5°C

1.4±0.1

3.9±0.1

1.9±0.1

5.6±0.5

28.4% methanol; 0.16 g/cm3; 5°C

1.4±0.1

4.0±0.4

2 0

. ±0 .2

4.7±0.5

6.5% methanol; 0.19 g/cm3; 5°C

1.3±0.2

3.8±0.2

1.8±0.3

7.4±0.5

6.5% methanol; 0.19 g/cm3; 25°C

1.3±0.1

3.7±0.1

1 8

. ±0 .1

7.6±0.3

6.5% methanol; 0.19 g/cm3; 45°C

1.3±0.1

3.8±0.1

1 8

. ±0 .1

7.5±0.3
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The protein was modelled as an oblate ellipsoid and screened coulombic
potential was used as the intermolecular potential. The parameters volume fraction,
temperature, dielectric constant, ionic strength, SLD of protein and solvent were all fixed,
and the parameters Ra, Rb, charge and incoherent background were allowed to vary. Plots
of ln I(Q) vs Q for HSA solutions (0.04 g/cm3) in D 2 O, 19.9% methanol and 23.4% glycerol
in the absence of NaCl and at 25 °C are shown in Figure

6

and the fitted parameters

presented in Table 4. The symbols are the experimental data and the dashed lines the results
of the fitting. The first correlation peak becomes prominent in the absence of NaCl. The
ellipsoid used in this work to fit the data is similar to the one used by Sjoberg and
Mortensen [35] who modeled HSA at a concentration of 0.26 g/cm3 as an oblate ellipsoid
of semi axes Ra =1.9 nm and Rb =

6 .8

nm.

Figure 7. Kratky plots showing the ffect of cosolvents on HSA at 0.04 g/cm 3
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Figure 8 . Experimental data for HSA in D 2 O at high concentrations with its
corresponding fits

Figure 9. Effect of cosolvents on HSA at high concentrations
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But it is quite different than the data reported by Carter et al. who modeled HSA
at a concentration of 0.12 to 0.18 g/cm3 as an oblate ellipsoid of semi axes 14 and 4 nm
[12]. The variations in Ra and Rb are not statistically significant but the increase in charge
is. Notice that the size and the shape of the scatters in the presence and absence of NaCl
are the same within the statistical noise.
The degree of compactness of the protein can be determined using a Kratky plot. A
plot of Q2. I(Q) vs Q for the two cosolvents in comparison with D 2 O is shown in Figure 7.
The three curves shown in Figure 7 for HSA at 0.04 g/cm 3 have a bell-shaped curve, which
is a characteristic of globular macromolecules. The maxima in Figure 7 are located at 0.656
(glycerol), 0.684 (D2O) and 0.704 (Methanol). Therefore, the protein takes a more
extended configuration as the solvent is changed from glycerol to water to methanol.
Plots of ln I(Q) vs Q with its corresponding fits for HSA in D 2 O at various
concentrations and in the presence of the two cosolvents are shown in Figures

8

and 9. As

the concentration increases from 0.04 g/cm 3 to 0.3 g/cm 3 there is a clear shift of the peak
towards higher Q values (Figure 8 ); so, the scatters are closer to each other. A comparison
of the effect o f methanol and glycerol at higher protein concentrations is shown in Figure
9. The correlation peak in the presence of glycerol moves towards higher Q values whereas
methanol has the opposite effect. There is an increase in the apparent charge as we move
from methanol, to water and to glycerol. This suggests an increase in repulsions; the
solution becomes more liquid like.
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Figure 10. Effect of methanol on HSA in D 2 O at 5°C

Figure 11. Effect of methanol on HSA in D 2 O at 25°C
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Figure 13. Effect of temperature for HSA in D 2 O at 0.303 g/cm3
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Figure 14. Effect of temperature on HSA in D 2 O at 6.5% methanol and 0.19 g/cm 3

Figure 15. Effect of temperature on HSA in D 2 O at 28.4% methanol and 0.16 g/cm 3
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The effect on the structure of the HSA solution of increasing amounts of
methanol at 5, 25, and 45oC is shown in Figures 10, 11 and 12 respectively. The symbols
are the experimental points and the lines the best fits. The figures show that the intensity
of the first correlation peak increases and the peak moves towards lower Q values as the
methanol concentration increases (Figures 10-12). Although it is possible that this pattern
is cause by the aggregation of the protein, the typical bending upwards o f the scattering
curve that reflects the presence of large aggregates is absent.
The FT-IR experiments indicate that no changes in the ternary or secondary
structure of the protein that will expose more hydrophobic groups to the solvent are taking
place. The addition of methanol is effectively decreasing the range of the force and this is
captured by the screened potential as a decrease in the net charge.

Figure 16. Interparticle structure factor calculations for HSA at 0.04 g/cm 3 in the presence
of different solvents
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Figure 17. Interparticle structure factor calculations for HSA at higher concentration
in the presence of different solvents

Figure 18. Interparticle structure factor calculations for HSA at 5°C and different
methanol concentrations
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Figure 19. Interparticle structure factor calculations for HSA at 6.5% methanol and
different temperatures

The effect of temperature on the scattered intensity in D 2 O, 6.5% and 28.4%
methanol concentrations is shown in Figure 13-15 respectively. The lines represent the best
fit using the same approach described above. The fitted parameters are shown in Table 4.
The curves in D 2 O and low methanol concentrations are almost identical. Aggregation has
likely occurred at 45°C and 28.4% methanol.
The interparticle structure factor (S(Q)) for HSA at various conditions was
calculated using Hayter-Penfold rescaled mean spherical approximation (HPMSA) for a
system of charged particles in a dielectric medium [23,36,37]. The fitted parameters
(equivalent radius, charge and incoherent background) obtained in the fitting of I(Q) were
used. The results are summarized in Figures 16-19. Figures 16 and 17 show a plot of S(Q)
vs Q at 25°C for D 2 O, 19.3% methanol and 23.4% glycerol for HSA at 0.04 g/cm 3 and 0.22
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g/cm 3 respectively. The cosolvents show an almost identical on the structure of the
solution. The effective radius increased from 1.6 nm for D 2 O to 2.0 nm for both methanol
and glycerol at low protein concentration which shifted the peak towards lower Q-values
for both the solvents. Similarly, when the concentration of the protein is increased (Figure
17), the effective radius increased from 1.3 nm for D 2 O to 2.0 nm for both methanol and
glycerol respectively. The dielectric constants of both methanol (70) and glycerol (70.2)
are smaller than the one for water (78). Therefore, the screened coulombic potential should
become stronger in the presence of the solvents. The charges used to calculate S(Q)
decrease in the order methanol<glycerol<D 2 O at low protein concentration while at higher
concentration it is methanol<D 2 O <glycerol. Therefore, the potential should be stronger in
the presence of glycerol and weaker in the presence of methanol.
Figure 18 shows calculated S(Q) for various concentrations o f methanol at a protein
concentration equal to 0.16 g/cm 3 and 5°C. As the cosolvent concentration increases, the
peak in S(Q) moves towards lower Q values. Both the dielectric constant and the effective
charge decrease as the concentration of methanol increases. The net result is a decrease in
the intermolecular potential as the concentration of the alcohol increases. A similar trend
is observed at 25°C. A negligible effect of temperature on S(Q) has been found (Figure 19).
It has been shown 30 that the addition large amounts of methanol (50%) causes proteins to
“swell” exposing more of the hydrophobic core but simultaneously to increase the amount
of secondary structure (alpha helixes). Those effects are caused by direct binding of
methanol to the polypeptide change via single hydrogen bonds and by indirectly increasing
intramolecular polar interactions. We do not observed that here since the size of the protein
remains nearly constant from 6.5% to almost 30% methanol.

39
4. CONCLUSIONS

HSA shape changed from a prolate to an oblate ellipsoid in the absence of
intermolecular forces as the protein concentration was increased. At higher concentrations
and in the presence of intermolecular forces the size and shape of the protein remains
invariant within the statistical noise. By fitting the experimental data with a simple model,
we demonstrated that the protein solution becomes more liquid like (more disordered) in
the presence of methanol and more crystal like (more ordered) in the presence of glycerol.
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II. E F F E C T O F D IFFER EN C ES IN TH E PRIM A RY STRU CTU RE O F TH E ACH AIN ON TH E A G G R EG A TIO N O F INSULIN FRA G M EN TS

A BSTRACT

Bovine and human insulin have similar primary structures. In this article, the region
of the insulin A-chain of bovine and human insulin where the amino acid composition is
different was studied. Bovine (BIF) and human (HIF) fragments were synthesized in solid
phase peptide synthesis. The effect of pH, temperature, urea, ionic strength and stirring on
the formation of fibrils was studied using a fractional factorial resolution III experimental
design. Fibrillation was monitored by fluorescence and infrared spectroscopy and optical
microscopy. Both fragments formed fibrils at pH 1.6 and a temperature of 60°C. The lag
time and apparent aggregation growth rate constant were determined using a two-parameter
kinetic model. It was found that the bovine insulin fragment has a shorter lag time than the
human insulin one while the exponential phase rate was faster for HIF than for BIF. An
increase in P-sheets content with time was observed in both fragments. The increase in Psheets was preceded by an initial decrease in a-helices followed by an intermediate
increase during the transition from the lag phase to elongation phase. Temperature and
ionic strength are among the most important experimental factors during the lag phase
whereas ionic strength is replaced by pH during the elongation phase for both the
fragments. Congo red binding confirmed the presence of ring-like oligomer structures rich
in anti-parallel P-sheets which tend to form fibrils rich in parallel P-sheets.
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1. IN TRO D U C TIO N

Protein aggregation is a major problem found in the bioprocessing industry.
Aggregation can occur at any step, from production to purification and packing [1]. Protein
therapeutics might lose their biological activity and cause problems during treatment if
they aggregate. Proteins can form aggregates both in their native and denatured state. They
can aggregate either during the lyophilization step or during their long-term storage.
Aggregation also happens during the unfolding/refolding reaction in the production of
recombinant proteins.
Protein aggregation in vivo is associated with disease. Formation of amyloid fibrils
is the manifestation of various amyloidogenic diseases like Alzheimer’s, neurofibrillary
tangle, neurodegeneration, Parkinson’s, etc. A total of 36 proteins/ peptides have been
identified to form amyloid fibrils in vivo till 2016 [2 ]. Amyloid fibrils are P-sheet rich
linear aggregates formed from circular oligomers. X-Ray diffraction of amyloid fibrils
shows a cross-P diffraction pattern which is a trademark o f intermolecular P-sheet
structures [3-6]. This intermolecular P-sheet structure is easily identified by FTIR. It has
been recently proved that oligomers are the elemental blocks to build a fibril [7,8]. The
propensity to form amyloid fibrils seems to be correlated with the hydrophobicity of
proteins [9]. In spite of its association with disease, amyloid aggregates can also be used
as scaffolds, as peptide hormones storage and natural adhesives [ 1 0 ].
Although amyloid fibrils are mostly related to disease causing proteins, it was also
reported that if appropriate incubation conditions were provided even a non-pathogenic
protein can form a fibrillar structure [11]. Fibrils can also be synthesized in vitro by
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subjecting the protein to favorable destabilizing conditions [12,13]. For example, hen
lysozyme incubated at pH 2.0 and 37°C forms fibrils [14].
Insulin aggregates at acidic pH and high temperature [15]. Insulin is a highlyconserved hormone exhibiting minor differences in the amino acid sequence from species
to species. For instance, Ala replaces Thr at position 8 , Val replaces Ile at position 10 and
Ala replaces Thr at position 30 in bovine and human insulin respectively [16]. Our previous
studies showed that the aggregation kinetics (both lag times and rate constants) is very
different for bovine and human insulin [17]. Moreover, dynamic light scattering and FTIR
experiments showed that both insulins seem to follow different aggregation pathways as
shown by different populations of aggregate sizes and different secondary structure
changes. Still, mature fibrils were practically identical. Previously, it was demonstrated
that the B chain fragment LVEALYL plays a key role in aggregation [18]. A recent review
shows that different insulin analogues show different aggregation pathways [19]. In an
attempt to identify the causes for those differences in the aggregation kinetics, we decided
to study fragments of the insulin A-chain containing the sequence where bovine and human
insulin are different [16]. Insulin A-chain is a 21-residue peptide in which only the amino
acids at positions

8

and 10 differ for bovine and human insulin [20]. Bovine insulin has

alanine and valine at positions

8

and

10

whereas human insulin has threonine and

isoleucine. We selected the sequences ASVCSLYQLENK 3 (BIF) and TSICSLYQLENK 3
(HIF) for the bovine and human fragments respectively. Bold letters identify the amino
acids that are different in both fragments. A lysine tail was added to each fragment to
increase its solubility [2 1 ].
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To study the effects of temperature, urea, ionic strength, pH and stirring on the
fibrillation process, a screening experimental design was chosen. The factors were chosen
based on the following criteria. Temperature affects protein folding and therefore the
formation of the nuclei. Urea, a known chaotropic, was chosen to study the effect of water
structure on fibril formation.

Table 1. Experimental design FF0508
Run

pH

Temp.
[°C]

Urea
[M]

Ionic
[M]

Stirring

1

-

-

-

-

+

2

-

-

+

+

-

3

-

+

-

+

-

4

-

+

+

-

+

5

+

-

-

+

+

6

+

-

+

-

-

7

+

+

-

-

-

8

+

+

+

+

+

Ionic strength and pH affects coulombic interactions among the side chains of
amino acids which affects fibrillation. Interfaces (solid/liquid or gas/liquid) induce protein
aggregation. Air was incorporated into samples by stirring to study the effect of gas/liquid
interfaces on fibrillation. The evolution of the aggregation process with time was monitored
using a thioflavin T (ThT) fluorescence assay. Secondary structure changes were
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monitored using attenuated total reflection (ATR)-FTIR spectroscopy. The presence of
Congo red stained fibrils [22] was confirmed by light microscopy.
pH, temperature, urea, ionic strength and stirring were chosen as factors for the
experimental design. A two-level fractional factorial design FF0508 o f resolution III as
shown in Table 1 consisting of five factors at two levels each with a total of 8 runs was
chosen.

Table 2. Experimental factors with lower and higher
levels

Factor

-

+

pH

1.6

5

Temperature

25°C

60°C

Urea (M)

0

1

Ionic Strength (M)

0.02

1

Stirring

Off

On

Each main effect in this design was confounded with one or more two-factor
interactions. The lower and higher levels chosen for the factors are shown in Table 2.
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2. EX PER IM EN TA L SECTIO N

2.1. M A TERIA LS
All Fmoc amino acids, Wang resin and HBTU were purchased from CS BIO Co.
(USA). ThT was purchased from Acros Organics (USA). Piperidine, DMF, TFA, DIPEA
and deuterium oxide; 99.9 atom % D were purchased from Sigma-Aldrich (USA). All other
solvents were purchased from Fischer Scientific (USA).

2.2. PE PT ID E SYNTHESIS
The peptides BIF and HIF were synthesized in a CS Bio 336 peptide synthesizer
using Fmoc technique in solid phase peptide synthesis [61]. Wang resin (0.5 mmol/g) was
used as a solid support matrix for this purpose and the synthesis was carried out from the
C- to the N- terminus [62]. One mmol per synthesis of each Fmoc amino acid was used.
Deprotection of Fmoc group was done using 20% piperidine in DMF. HBTU combined
with DIPEA was used as an activator to facilitate the coupling of amino acids. The
complete synthesis took approximately 18 hours. The product from the reaction vessel was
suspended in DCM and the peptide was cleaved from the swollen resin using 95% TFA.
The cleaved peptide was then re-suspended in cold diethyl ether and centrifuged twice
using RC-3B Refrigerated centrifuge, (Sorvall Instruments) at 4650 x g, -5°C for 30 min.
The obtained pellet was dissolved in 10 mM acetic acid and lyophilized to obtain the final
peptide fragment.
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2.3. N M R SPEC TR O SC O PY
The amino acid composition of the peptides was confirmed using liquid state one
dimensional (1D) 1H NM R spectroscopy. Samples for the analysis were prepared by
dissolving 10 mg of the peptide in 750 pl D 2 O (99.9 % Deuterium). Spectra were obtained
using a Bruker 400-MHz spectrometer equipped with a BBO probe. 1H NM R data were
obtained with a sweep width of 3997.8 MHz, 0.256 s acquisition time, 16 scans and a 2s
recycle delay.

2.4. MASS SPEC TR O M ETR Y
To determine the purity and the mass of the peptides LC-MS data were acquired on
an Agilent 6520 Q-TOF LCMS system. Lyophilized peptides were suspended in 0.1%
formic acid in water to obtain a final concentration of 1mg/ml. 5 pL of the sample was
loaded on an Agilent Technologies 43mm C18 Chip column. Agilent Technologies 1200
Series Quaternary HPLC was used. LC Gradient: initial conditions 3% B (A: 0.1% formic
acid in water; B: 99.9% acetonitrile, 0.1% formic acid), gradient to 80% B over 9 min, hold
at 80% B for 3 min, ramp back to (0.5 min) and hold at (2.5min) initial conditions. An
Agilent Technologies 6520A Accurate Mass QTOF MS with integrated Chip Cube source
was used to collect data. Data across a total of 15 minutes of elution were collected. MS
data were collected between 295 and 2500 m/z and MS/MS data were collected between
70-2500 m/z at 2 spectra/sec. Peptides with counts >2000 were picked for MS/MS.
LC-MS for the fibrils was obtained using an LTQ Orbitrap XL mass spectrometer.
Samples were precipitated using ice-cold acetone. The pellet was recovered by
centrifugation (16,000 x g) and washed twice with 80% acetone (in water). The pellet was
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dried and resuspended in 100 pL of urea buffer (6M urea, 2M thiourea, 0.1M ammonium
bicarbonate). No particulates were observed, suggesting fibrils were completely dissolved
in the buffer.

2.5. IN V ITR O FIB R IL LA TIO N
Samples were prepared with a peptide concentration of 10 mg/ml. A total of 16
samples, 8 for each fragment varying the experimental conditions were made. All the
samples were prepared in 0.22 pm filtered phosphate buffer at their respective pH (1.6 and
5). Urea and sodium chloride with two different concentrations were added. Samples were
incubated with ThT at two different temperatures (25°C and 60°C) under stirring and no
stirring conditions. The evolution of the fibrillation process with time was followed by
fluorescence assay and the changes in secondary structure were studied using FT-IR. The
water used for the preparation of buffers was purified to a resistivity of 17.5 MQ.cm.

2.6. TH T FLU O R ESC EN C E ASSAY
ThT assay was done using a NanoDrop 3300 Fluorospectrometer (Thermo Fisher
Scientific) using white light as the excitation source (460-650nm). The emission
wavelength was set to 482 nm. Free dye has an excitation wavelength of 385 nm and an
emission wavelength o f 445 nm. A stock solution for the ThT assay was prepared by adding
0.8 mg of ThT dye to 50 ml of 0.22 pm filtered phosphate buffer (pH 7) and stored at 4 °C
in a dark place to prevent quenching. 0.05 mM of ThT solution was added to each sample
at the beginning of incubation. A ThT solution with only the buffer was used as a blank for
the assay. Fluorescence for each sample was recorded every three days. Increase in
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viscosity or the appearance of gel/ precipitate with time upon visual inspection is a
characteristic of the ThT assay [22]. All the reported fluorescence readings were an average
of 5 replicates.

2.7. F T IR ANALYSIS
Analysis was carried out with a Nicolet 6700 FT-IR spectrometer from
Thermoscientific equipped with a KBr beam-splitter and a DTGC detector cooled by liquid
nitrogen. A smart performer Attenuated Total Reflectance sampling accessory with a
Germanium (Ge) crystal was used. Interferograms were obtained for each sample at a
resolution of 16 cm-1 and 256 scans were collected for each run to obtain a good signal-tonoise ratio.

2.8. CO NG O RED STAINING
Congo red dye was used to stain and obtain the micrographs of the fibrils. A stock
solution was prepared by adding 7 mg of Congo red to 1 ml o f 0.22 pm filtered water.
Samples containing fibrils were first centrifuged using a micro centrifuge at 9450 x g and
then washed thoroughly with water. The pellet was then resuspended in 1 ml of water and
5 pL of Congo red solution was added and incubated at 25 °C for one hour. After obtaining
a red precipitate, the sample was centrifuged again. The pellet was washed twice with water
to remove the unattached dye. The fibrils were then resuspended in a small amount of
water. 30 pL of Congo red stained fibrils were placed on a microscopic slide and air dried.
Micrographs were obtained at 1000x using Hirox KH-8700 digital microscope.
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3. RESU LTS AND DISCUSSION

The amino acid composition of both BIF and HIF was determined using 1H NMR
spectroscopy. 1H resonance assignments for each amino acid were done based on its
corresponding proton chemical shifts. All the data related to proton chemical shifts was
obtained from the Biological Magnetic Resonance Data Bank [23]. Figure 1 and 2 shows
the full 1H NMR spectra for BIF and HIF respectively with their corresponding amino acid
resonance assignments for various protons.

Figure 1. 1H NM R spectrum of BIF highlighting the chemical shifts corresponding to
Alanine and Valine at 25°C
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Figure 2. XH NM R spectrum o f HIF highlighting the chemical shifts corresponding to
Threonine and Iso leucine at 25°C

Both spectra look similar with a few minor differences in the peaks at the backbone
and the sidechain region. Figure 1 has peaks at 4.25 ppm, 1.35 ppm, 4.17 ppm and 2.28
ppm which correspond to Ala Ha, Ala Hp, Val Ha and Val Hp respectively and seen only in
BIF. Similarly Figure 2 has peaks at 4.38 ppm, 4.11 ppm, 3.99 ppm and 1.78 ppm which
correspond to Thr Ha, Thr Hp, Ile Ha and Ile Hp respectively and seen in only HIF. Peaks
assigned to rest of the amino acids are same in both the fragments (Table 3 and 4).
The purity and mass of both peptide fragments were calculated from the LC-MS
data obtained using a Q-TOF LC/MS system. Figures 3 and 4 show the relative abundance
and mass for native BIF and HIF respectively. The purity o f the samples was calculated
based on the relative abundance of each fraction. BIF full intact peptide (1-3 Lysines at the
tail) has a purity of 72%. The major impurity found in both peptides is a Fmoc group (mass
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of 164 Da) due to an inefficient final deprotection step.

Fmoc attached peptide

(impurity) is ~ 28% in BIF while it is ~ 66 % in HIF (53% Fmoc full peptide plus 13 %
Fmoc with no Thr). Since the peptides were used without further purification, it is
important to determine the composition of the fibrils obtained in the experiment using LCMS to estimate the effect of the impurity on fibrillation.

Table 3. 1H NM R chemical shifts for BIF
Proton chemical shift (ppm)
Amino Acid

Ha

Hp

Hy

Hs

He

Ala

4.25

1.35

-

-

-

Ser

4.46

3.65

-

-

-

Val

4.17

2.28

0.96

-

-

Cys

4.62

3.32

-

-

-

Leu

4.35

1.77

-

0.66

-

Tyr

-

2.84

-

7.07,6.59

-

Gln

4.21

2.09

2.5

-

6.67

Glu

4.01

1.9

2.24

-

-

Asn

-

2.76

-

-

-

Lys

4.29

1.81

1.39

1.58

2.88
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Table 4. 1H NM R chemical shifts for HIF
Proton chemical shift (ppm)
Amino Acid

Ha

Hp

Hy

Hs

He

Thr

4.38

4.11

1.09

-

-

Ser

4.46

3.65

-

-

-

Ile

3.99

1.78

1.21

0.67

-

Cys

4.62

3.32

-

-

-

Leu

4.35

1.77

-

0.66

-

Tyr

-

2.84

-

7.07,6.59

-

Gln

4.21

2.09

2.5

-

6.67

Glu

4.01

1.9

2.24

-

-

Asn

-

2.76

-

-

-

Lys

4.29

1.81

1.39

1.58

2.88

Four samples, one with high P-sheet content (pH 1.6, 60°C, 1M urea, 0.02M NaCl)
and the other with low P-sheet content (pH 5, 25°C, 1M urea, 0.02M NaCl) for both BIF
and HIF were chosen for this analysis. Aggregates formed at pH 5 and 25°C in both the
fragments consist of 93% Fmoc (BIF) and 100% HIF attached peptide in abundance as
shown in Figures 5 and 6.
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Figure 3. LC-MS of native BIF showing the native BIF (with 1 and 3 Lys tail) and
impurity (Fmoc-BIF)

Figure 4. LC-MS of native HIF showing the native HIF, truncated HIF (with Fmoc)
and impurity (Fmoc-HIF)
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Bovine6-1000_XT_00001_M_ #2 RT: 2.00
T: FTMS + p NSI Full ms [300.00-2000.00]

AV: 1

NL: 6.60E7

m/z

Figure 5. LC-MS graph of fibrils obtained after the experiment for BIF at pH 5, 25°C,
1M urea, 0.02M NaCl showing the relative abundance of Fmoc-BIF

Human6-1000_XT_00001_M_ #2 RT: 2.00
T: FTMS + p NSI Full ms [300.00-2000.00]

AV: 1

NL: 1.49E6

Figure 6. LC-MS graph of fibrils obtained after the experiment for HIF at pH 5, 25°C
1M urea, 0.02M NaCl showing the relative abundance o f Fmoc-HIF
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Figure 7. LC-MS graph of fibrils obtained after the experiment for BIF at pH 1.6,
60°C, 1M urea, 0.02M NaCl showing the relative abundance of Fmoc-BIF

Figure 8. LC-MS graph of fibrils obtained after the experiment for HIF at pH 1.6,
60°C, 1M urea, 0.02M NaCl showing the relative abundance of Fmoc-HIF
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While at pH 1.6 and 60°C, fibrils in BIF consist of equal amounts of native and
Fmoc attached peptide but HIF fibrils are made o f 74% Fmoc HIF, 22% truncated Fmoc
HIF and only 4% HIF (Figure 7 and 8). Finally, both BIF and HIF at pH 1.6 and 60 oC
shows deamidation of Asn to Asp, but this is not observed at pH 5 and 25 °C. Deamidation
is favored by low pH and high temperature. It is not clear if deamidation occurred before,
during or after the formation of the aggregates. Deamidation may occur by acid/base
catalysis as well as by intramolecular nucleophilic catalysis.
One commonly used mechanism to explain fibril formation consists of three phases:
1) nucleation/lag, 2) elongation/exponential growth and 3) equilibrium/ precipitation [24].
The process begins with a lag phase where there is no significant change in the soluble
peptide concentration. Nuclei/oligomer structures are formed by partly denatured peptides
[25,26]. The lag phase is followed by an elongation or the exponential growth phase where
the size of the fibrils increases by addition of preformed oligomer structures to
protofilaments [27,28]. Finally, it reaches an equilibrium/precipitation phase where most
of the soluble peptide has been converted into fibrils.
The process of fibril formation was studied using ThT fluorescence assay and the
changes in the secondary structure were simultaneously determined using ATR-FTIR. ThT
bound to amyloid-like fibrils show a strong fluorescent signal [29]. ThT dye does not bind
to either soluble peptides or to amorphous aggregates [30]. ThT-induced spectral changes
for various amyloidogenic proteins are qualitatively identical irrespective of the primary
structure, this feature is important when comparing two slightly different peptides [31].
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Relative Fluorescence Units

Figure 9. ThT fluorescence plots showing the fibril formation process with time for
BIF at all the runs

Figure 10. ThT fluorescence plots showing the fibril formation process with time for
HIF at all the runs

62
Figures 9 and 10 show relative fluorescence vs time at all experimental
conditions for BIF and HIF respectively. Representative error bars are included in both
figures. Most curves show a characteristic sigmoidal shape consisting of three regions: a
lag phase, an exponential phase and an equilibrium phase. Therefore, the kinetics of fibril
formation can be characterized by a lag time (tlag) and apparent aggregation growth rate
constant (Kapp). The obtained sigmoidal curves for each run were curve fitted using non
linear curve fit in Origin Pro data analysis software to determine tlag and Kapp by [32]:
_
1
y _ i+e(x-xo)/dx

(1)

where y is the fluorescence intensity for the normalized data, x is the time in days, xo is the
time at 50% fluorescence intensity and dx is the time constant. From Eq.1 the lag time (tlag)
and apparent aggregation growth rate constant (Kapp) can be calculated using tlag = (x0 2 dx) and Kapp =1/ dx. The calculated lag time (tlag) and apparent aggregation growth rate
constants (Kapp) for both BIF and HIF are shown in Table 5.
All the runs for BIF formed fibrils while 2 of the 8 runs for HIF (pH 1.6, 25°C, 1M
urea, 1M NaCl; pH 5, 25°C, 1M urea, 0.02M NaCl) are still in the lag phase after 8 weeks.
This finding suggests that HIF does not form nuclei at room temperature in the presence of
urea irrespective of the other conditions. In contrast, HIF at room temperature in the
absence of urea (pH 1.6, 25°C, 0M urea, 0.02M NaCl; pH 5, 25°C, 0M urea, 1M NaCl)
form fibrils.
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Table 5. Lag times (tiag) and apparent aggregation growth rate constants
(Kapp) calculated for both BIF and HIF

Run #

Bovine

Human

tlag (days)

Kapp (day-1)

tlag (days)

Kapp (day-1)

1

12 ± 1

0.85 ± 0.37

30 ± 2

0.18 ± 0.02

2

16 ± 1

0.53 ± 0.16

-

-

3

12 ± 1

0.51 ± 0.10

22 ± 1

0.62 ± 0.07

4

11 ± 2

0.22 ± 0.05

24 ± 2

0.47 ± 0.16

5

14 ± 1

0.94 ± 0.13

13 ± 2

0.99 ± 0.63

6

14 ± 2

1.51 ± 0.15

-

-

7

7± 1

0.29 ± 0.04

20 ± 1

0.70 ± 0.17

8

11 ± 2

0.57 ± 0.22

15 ± 1

0.73 ± 0.18

BIF has shorter lag times than HIF under all incubation conditions. The lag times
are shorter at higher temperatures under all conditions for both BIF and HIF. This
dependence on temperature was also observed in native bovine and human insulin [17].
Though the lag times are shorter for BIF than HIF (at the same conditions), the rate of
aggregation is faster for HIF than BIF except for run #1 (Table 1). The lag time is the
shortest for BIF at pH 5, 60°C, no urea, 0.02M NaCl (7 ± 1 days) and it is the longest for
BIF at pH 1.6, 25°C, 1M urea, 1M NaCl (16 ± 1 days).
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Figure 11. Pareto charts showing the effect of various factors based on Tiag as an
outcome from the experimental design FF0508 for BIF

Figure 12. Pareto charts showing the effect of various factors based on Tlag as an
outcome from the experimental design FF0508 for HIF
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Figure 13. Pareto charts showing the effect of various factors based on Kapp as an
outcome from the experimental design FF0508 for BIF

Figure 14. Pareto charts showing the effect of various factors based on Kapp as an
outcome from the experimental design FF0508 for HIF
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For HIF, lag time is the shortest at pH 5, 25°C, 0M urea, 1M NaCl (13 ± 2 days)
while it is the longest at pH 1.6, 25°C, 0M urea, 0.02M NaCl (30 ± 2 days). At 1M urea
and 0.02M NaCl, samples at the lowest pH and highest temperature (BIF and HIF at pH
1.6, 60°C) have a shorter lag time than samples at the highest pH and lowest temperature
(BIF and HIF at pH 5, 25°C).
Pareto charts using tlag or Kapp as an outcome are shown in Figures 11,12 and 13,14
respectively. The important factors using each outcome were identified using the Pareto
principle [33]. The important factors during lag phase are temperature, ionic strength and
urea for BIF while for HIF temperature, pH and ionic strength are significant. Although all
the factors seem to be important during the elongation phase for HIF, temperature and pH
are the most important ones which is also true for BIF. The pH is of importance during
elongation phase as it affects the interactions among the side chains of amino acids leading
to the formation of fibrils. The presence of gas/liquid interfaces has a negligible effect on
fibrillation.
Exposure of hydrophobic surfaces to water plays an important role in the formation
of fibrils [34]. Hydrophobicity of each amino acid residue can be assigned from the native
structure according to the hydrophobicity scale of Kyte and Doolittle in the UCSF Chimera
package [35,36]. The native peptide structures were generated using a web server PEPFOLD 3 [37]. The structures shown in Figures 15 and 16 correspond to BIF and HIF
respectively. Models were visualized using the UCSF Chimera package [36]. The residues
in each peptide are shown in various colors according to their hydrophobicity. Colors range
from blue for the most hydrophilic to white (neutral) to orange for the most hydrophobic.
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Figure 15. BIF fragment visualized using UCSF chimera package with variations in
colors according to their hydrophobicity

ILE

Figure 16. HIF fragment visualized using UCSF chimera package with variations in
colors according to their hydrophobicity
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BIF has alanine and valine which are replaced by threonine and isoleucine in HIF
at their respective positions. Comparing the hydrophobicity indexes, alanine (47), valine
(79) and isoleucine (99) are very hydrophobic amino acids at both acidic and basic pH
compared to threonine which is a neutral amino acid (13) [38]. The presence of an extra
hydrophobic residue for BIF over HIF could be the reason for shorter lag times observed
with BIF. However, BIF shows a slower growth rate than HIF. This suggests that the nuclei
of both peptides are structurally different.
The formation of intermolecular P-sheet secondary structure is one criterion used
to label an aggregate as an “amyloid fibril” [22]. The changes in the secondary structure of
peptides can be followed by FTIR [39]. Moreover, ATR-FTIR plays a prominent role in
differentiating the oligomers (anti-parallel P-sheets) from fibrils (parallel P-sheets) [40].
Therefore, IR spectroscopy is an alternative method to complex techniques like X-ray
diffraction [41]. Second derivative analysis of the spectra allows the determination of
protein secondary structure [42]. The number of peaks from the deconvolved spectra
should be chosen carefully. It is necessary to confirm that the maximum frequency of the
curve-fit peaks correspond to the maxima evident in the raw data to ensure that the peak is
assigned to its specific secondary structure [43]. The precision of the calculated peak areas
from the second derivative spectra largely depends on the baseline chosen while fitting
[39]. Origin Pro peak fit analysis has various baseline modes for this purpose.
The relevant region in the spectra is the Amide I region (1600-1700 cm-1), which is
caused by the carbonyl group stretching vibrations from the peptide backbone [44]. Each
structural conformation has a unique C=O vibration dependent on its hydrogen bonding
pattern [45]. One major limitation with the spectra is that the Amide I peak has a maximum
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at ~1650 cm-1 that coincides with the water maximum absorption at ~1643 cm-1. The
water background needs to be carefully subtracted from the spectra. The use of an ATR
attachment avoids this problem and allows data collection with minimal use of sample [46].
A flat baseline obtained between 2200 to 1800 cm-1 is often considered a standard to
confirm proper water subtraction [47]. Absorption of the side-chains also cause spectral
deviation during the analysis. Carbonyl group vibrations for asparagine and glutamine
occur at around 1678 cm-1 and 1670 cm-1 which can affect the spectra [48]. Urea also has
an absorption peak in the amide I region which can be deceptive [49]. Hence during the
background subtraction for the samples in the presence o f urea, 20 pl of 1M urea was added
to the blank to subtract the undesired peaks.

Figure 17. Second Derivative spectra for native BIF and its curve fitted peaks
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FTIR analysis of the native peptide fragments shows an a-helix content of 52.6
% and 53.9 % for BIF and HIF respectively while the rest of the structure are random coils
(Figures 17 and 18). The calculated secondary structures for both peptides predicted by
PEPFOLD3 are 42.9 % and 64.3 % a-helix for both BIF and HIF (the rest being random
coils). The secondary structure is calculated using DSSP, a hydrogen bond estimationbased algorithm by the secondary structure server [50]. PSIPRED and Porter 4.0 protein
servers also confirmed that both the peptides consist of a-helices and random coils [51].
Comparing the experimental and theoretical values of a-helix content, BIF has ~82 % Q3
accuracy while HIF has ~81% Q3 accuracy, which are acceptable [52].

Figure 18. Second Derivative spectra for native BIF and its curve fitted peaks
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Figure 19 shows the FTIR spectra of BIF at pH 1.6, 60°C, 1M urea and 0.02M
NaCl collected during weeks 1 and 6. At time zero the amide I peak is centered at 1650
cm-1 but after 42 days the peak shifted to 1681 cm-1. This net band shift corresponds to an
a-helix to P-sheet transition with time [53]. By curve-fitting the deconvoluted spectra the
amount of each secondary structure was determined as shown in Figure 20, which
correspond to BIF at the above conditions during week-1. The integration of each curvefitted peak yields the total secondary structure content. At the end of week-1 (Figure 20),
three peaks are found around 1635, 1663 and 1689 cm-1. The bands around 1635 and 1689
cm-1 correspond to P-sheets/random coil and turns/anti-parallel P-sheets respectively
whereas the peak around 1663 cm-1 can be assigned to a-helix.

Figure 19. FTIR spectra for BIF at pH 1.6, 60°C, 1M urea, 0.02M NaCl collected at t
= 0 days ( Solid line) and t = 42 days (dashes) showing the shift in the amide I region
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At the end of week-6, four peaks around 1620, 1651, 1674 and 1681 cm-1 are
found. The peak at 1635 cm-1 during week-1 vanishes with time and the presence of a peak
around 1620 cm-1 during week-6 corresponds to an increase in P-sheet content. Researchers
previously reported that the fibrils show a new P band at ~1620 cm-1 as opposed to the
native FTIR P band at ~1635 cm-1 [54]. The peaks at 1620 and 1651 cm-1 can be assigned
to extended P-sheets and a-helix whereas the other two peaks correspond to P-turns/ anti
parallel P-sheets.

Figure 20. Second derivative spectra for BIF at pH 1.6, 60°C, 1M urea, 0.02M NaCl
collected at the end of week 1 and its curve fitted peaks
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Figure 21. FTIR spectra for HIF at pH 1.6, 60°C, 1M urea, 0.02M NaCl collected at t
= 0 days (black) and t = 42 days (red) showing the shift in the amide I region

Figure 22. Second derivative spectra for HIF at pH 1.6, 60°C, 1M urea, 0.02M NaCl
collected at the end of week 1 and its curve fitted peaks
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Similar analysis was also conducted on HIF and the secondary structure content
was determined (Figures 21 and 22). HIF peaks were located around same wavenumbers
as that of BIF (Table 6).

Table 6. FTIR deconvoluted peaks corresponding to HIF
at pH 1.6, 60 °C, 1M urea, 0.02M NaCl

Wavenumber (cm-1)

HIF

Week-1

Week-6

1633

1619

1667

1649

1686

1696

Figures 23 and 24 show plots for the change in the intermolecular P-sheet content
with time for both BIF and HIF respectively. All the runs show an increase in the
percentage of P-sheets with time. All BIF samples have a higher percentage of P-sheets
than HIF when incubated at the same conditions. The highest percentage of P-sheets was
found in BIF (34%) and HIF (31%) at pH 1.6, 60°C, 1M urea, 0.02M NaCl. HIF at 60 °C
for all runs has a higher percentage when compared to the one at 25 °C. As it is evident
from the plots, most of the increase in P-sheets occurred in the first two weeks of the
experiment for BIF and in the first three weeks for HIF. A comparison with ThT data shows
that the P-sheet increase occurs mostly during the lag times (12 days for BIF and 21 days
for HIF). Thus, the progression of lag phase to the elongation phase in both the fragments
can be assigned to the increase in the number o f P-sheets and their extension to form fibril.
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Figure 23. Evolution of the intermolecular p-sheets (%) with time (weeks) for BIF at
all the runs

Figure 24. Evolution of the intermolecular p-sheets (%) with time (weeks) for HIF at
all the runs
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The samples HIF at pH 1.6, 25°C, 1M urea, 1M NaCl and at pH 5, 25°C, 1M
urea, 0.02M NaCl are still in the lag phase at the end of the experiment, they have a P-sheet
content of 25.1 % and 24.6 % respectively. There is no specific criterion as to how much
of P-sheet percentage qualifies to be an amyloid fibril. According to ThT data, HIF at pH
5, 25°C, 0M urea, 1M NaCl forms fibrils whereas HIF at pH 1.6, 25°C, 1M urea, 1M NaCl
and at pH 5, 25°C, 1M urea, 0.02M NaCl do not; despite the fact that both peptides reach
an almost identical percentage of P-sheets. While there is an increase in the P-sheet content
with time for the rest o f the runs, these two runs have a constant P-sheet content. These
results are consistent with the ThT data (Figure 10).

Figure 25. Curve fitted plots for the evolution of the intermolecular P-sheets (%) with
time (weeks) for BIF at all the runs
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The data shown in Figures 23 and 24 was normalized and fitted with,

y = 1 - (Kp)l

(2)

where y is the normalized p-sheet percentage, t is the time in weeks and Kp is the rate of
increase in P-sheets. Figures 25 and 26 show the curve fitted P-sheet plots for BIF and HIF
respectively. All the fitted curves have an R-squared value of at least 97%. The Kp values
calculated for BIF and HIF are shown in Table 7. Kp values for BIF are similar for all the
runs but the Kp values for HIF are larger at 60°C than at 25°C.

Table 7. Rate of increase in P-sheets (Kp)
calculated for both BIF and HIF

Run #

Bovine

Human

Kp (week-1)

Kp (week-1)

1

0.50 ± 0.08

0.43 ± 0.05

2

0.46 ± 0.07

0.34 ± 0.06

3

0.47 ± 0.09

0.51 ± 0.11

4

0.51 ± 0.09

0.49 ± 0.06

5

0.48 ± 0.08

0.42 ± 0.06

6

0.49 ± 0.07

0.40 ± 0.02

7

0.52 ± 0.04

0.60 ± 0.05

8

0.42 ± 0.08

0.58 ± 0.07
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Figure 26. Curve fitted plots for the evolution of the intermolecular p-sheets (%) with
time (weeks) for HIF at all the runs

Figure 27. Pareto charts showing the effect of various factors based on Kp as an
outcome from the experimental design FF0508 for BIF
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Figure 28. Pareto charts showing the effect of various factors based on Kp as an
outcome from the experimental design FF0508 for H TF

At 25°C the rate of increase in p-sheets was higher in BTF than HTF while at 60°C
the rates were similar. The Kp value decreased with an increase in both urea and NaCl
concentration irrespective of other conditions. Using Kp as an outcome Pareto analysis was
conducted to determine the important factors (Figures 27 and 28). Temperature and pH are
the most significant factors for HTF which is also true for the lag and elongation phases
from ThT data (Figures 12, 14). Tonic strength and urea are the most important factors for
BTF. This is also true for BTF during lag phase but during the elongation phase, temperature
and pH are more important.
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Figure 29. a-H elix percentage change for BIF at all the runs

Figure 30. a-H elix percentage change for HIF at all the runs
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Figure 31. p-index plotted as a function of time at all the conditions for BIF

Figure 32. p-index plotted as a function of time at all the conditions for HIF
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Figures 29 and 30 show a plot of percentage change in the a-helix content with
time for BIF and HIF respectively for all runs. Both fragments show a decrease in a-helices
with time. Though there is consistent decrease in the a-helix content in both fragments
during the lag phase, a slight increase in a-helices can be seen during the transition from
lag phase to elongation phase. Formation of a-helical rich intermediates was also reported
previously in the fibrillation of a-Synuclein [55,56].
FTIR analysis was also used to distinguish oligomers from fibrils. Oligomers are
rich in anti-parallel P-sheets (1695-1680 cm-1) while fibrils are rich in parallel P-sheets
(1635-1620 cm-1) [40]. We calculated the P-index i.e., the ratio of (% of turns +
anti-parallel p-sheets) to % of parallel p-sheets using a similar protocol as previously
mentioned [57]. The P-index as a function of time was plotted for both the fragments as
shown in Figures 31 and 32 respectively. Its value decreases with increasing time, which
shows that samples rich in anti-parallel P-sheets (oligomers) convert to parallel P-sheet rich
fibrils. That transition from anti-parallel to parallel P-sheets confirms that oligomers are
the base unit of fibrillation.
The presence of fibrils was further confirmed using optical microscope. A recent
NM R study shows that Congo red binding is specific to fibrils [58]. The combination of
ThT and Congo red assays minimizes confounding because they are independent assays
[59]. Micrographs shown in Figure 33 contain irregular proteinaceous deposits when
stained with Congo red. These micrographs demonstrate the amyloid properties for BIF
and HIF at pH 1.6, 60°C, 1M urea, 0.02M salt (Figure 33 A, B) and pH 5, 60°C, 0M urea,
0.02M salt (Figure 33 C, D) respectively. At pH 1.6, BIF forms amyloid plaques (Figure
33A) whereas HIF forms distinct annular amyloid aggregates (Figure 33B) [60]. The
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maximum fluorescence intensity represents the maximum aggregation growth. This is
higher in HTF compared to BIF at pH 1.6 which explains the morphological differences.
Similarly, it is the same at pH 5 for both fragments showing aggregates of similar
morphology.

Figure 33. Micrographs showing the presence of fibrils for A) BIF at pH 1.6, 60°C,
1M urea, 0.02M NaCl B) HTF at pH 1.6, 60°C, 1M urea, 0.02M NaCl C) BIF at pH 5,
60°C, 0M urea, 0.02M NaCl D) HTF at pH 5, 60°C, 0M urea, 0.02M NaCl
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4. CONCLUSIONS

Two peptide fragments of insulin A-chain with subtle differences in their primary
structure were synthesized and their fibrillation propensity was studied using fluorescence
and infrared spectroscopy. We found that the bovine insulin fragments have a shorter lag
time in comparison with the human insulin ones but, for most samples, the exponential
phase rate was faster for HIF than for BIF. The presence of an Fmoc attached peptide has
an impact on the fibrillation kinetics which is dependent on pH and temperature. An
increase in P-sheets content with time was observed in both fragments. The increase in Psheets was preceded by an initial decrease in a-helices followed by an intermediate
increase during the transition from the lag phase to elongation phase. The conversion of
oligomer structures rich in anti-parallel P-sheets to fibrils rich in parallel P-sheets is a
characteristic of amyloid. The observed a-helix to P-sheet transition as well as the
micrographs obtained using Congo red staining confirmed the formation of ring-like
oligomer structures rich in anti-parallel P-sheets, which then form fibrils rich in parallel Psheets.
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III. E F FE C T O F G LY CO SY LA TIO N ON TH E A G G R EG A TIO N O F INSULIN
A-CHAIN FRA G M EN TS

A BSTRACT

The fibrillation of the amyloidogenic region of bovine and human insulin A-chain
was study at pH 1.6 and 60°C in the presence and absence of DTT. A bovine insulin
fragment (BIF) and a human insulin fragment (HIF) were glycosylated to form gBIF and
gHIF. A full factorial experimental design with three factors at two levels each was
conducted. The glycosylated peptides exhibited a much longer lag time than the nonglycosylated counterparts. BIF and HIF in the presence and absence of DTT show a
biphasic kinetics when the fibrillation is followed by turbidity but not by the ThT assay.
The fibrillation process consists of an initial transition from monomers or dimers to
globular oligomers followed by a transition from oligomers to curvilinear fibrils that
become rigid fibrils. Both BIF and HIF show prominent peaks for amyloid fibrils around
1620 cm-1 while the glycosylated peptides have aggregates still in the pre-fibrillar stage
after 42 days. Congo Red stained fibrils further confirm the presence of fibrils both in the
presence and absence of DTT.

1. IN TRO D U C TIO N

Proteins fold into a compact structure to carry out their specific biological
functions. However, under environmental stresses or because of mutations, they may
misfold leading to the formation of aggregates. Furthermore, loss of biological activity in
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protein therapeutics and problems during patient administration of drugs are associate to
the formation of aggregate [1]. Protein aggregation can happen at any stage during a
production process, from the recovery of intracellular recombinant proteins by an
unfolding/ folding reaction, to lyophilization, and long-term storage. Protein and peptide
aggregates

are also manifestations of various pathological conditions ranging from

disordered neurodegenerative patterns to systemic amyloidosis [2].
Amyloid fibril deposits and degeneration of neural networks are the most prominent
features found in many neurodegenerative diseases like Parkinson’s disease, multiple
sclerosis, amyotrophic lateral sclerosis and Alzheimer’s disease [3]. The number of
neurodegenerative cases have increased exponentially in the past decade [2]. Fibrils are
linear aggregates of proteins rich in intermolecular P-sheet structures that are formed from
circular oligomers as the building blocks [4,5]. It has been argued that any protein or
peptide can form fibrillar structures in vitro [6,7].
Although most proteins and peptides may form amyloid fibrils, the aggregation
pathways may be different from protein to protein and from species to species for the same
protein. At least ten different mechanisms were proposed over the years to explain the
formation of amyloid fibrils [2]. Three of the most popular are (1) monomer addition, (2)
two steps model o f nucleation and (3) secondary nucleation mechanism [8-10]. The
M onom er addition mechanism is observed in the aggregation of insulin. The existence of
self-complementary surfaces in insulin facilitates the formation of reversible oligomers.
These oligomers, over time, form irreversible aggregates [11]. Although some proteins do
not have the tendency to self-associate, conformational changes may induce the formation
of oligomers [12]. According to this mechanism, unfolding of a protein is not a necessary
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criterion for the proteins to aggregate. Instead, side-by-side or end-to-end union of
molecules causes aggregation. In the two-step model of nucleation, a primary nucleation
phase is followed by sigmoidal growth. In this aggregation process, monomers form critical
nuclei during the lag phase followed by an elongation/growth phase where fibril size
increases upon addition of pre-formed nuclei to form protofilaments [13-15]. As the
equilibrium phase is reached, most of the soluble protein has been converted into amyloid
fibrils. In the secondary nucleation m echanism , the fibrils formed during the primary
nucleation mechanism and the monomers undergo a secondary nucleation reaction to form
toxic oligomeric species [8]. This results in the formation of denser and longer fibrils.
The inhibition of amyloidogenesis is poorly understood despite the volume of
research done [16]. Post translational modifications like glycosylation, phosphorylation,
and lipidation affect the stability of a protein or a peptide [17,18]; and therefore, they may
prevent or retard fibrillation. There are a few examples about that in the open literature.
For example, fibrillogenesis was greatly retarded upon modification of a-helical hairpin
peptide using glycosylation or phosphorylation [19]. The glycosylated peptide gR4 of Tau
greatly showed a slower aggregation kinetics in comparison with its non-glycosylated
counterpart [20]. The size and number of glycan groups seems to affect different aspects
of protein stability differently. The glycan groups in native proteins may have a stabilizing
role because they increase the hydrophilicity of the peptide surface, which in turn increases
its solubility and inhibits aggregation [21]. The anomeric configuration of the sugar is one
of the most important factors affecting fibrillogenesis. For example, fibrillation of the prion
peptide was better inhibited by a-linked sugars than by P-linked sugars [22].
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Thermodynamic stability is also altered upon glycosylation. For example, the
endothermic

denaturation

temperature

of whey

protein

isolate

increased

upon

glycosylation [23].
The effect of subtle differences in the primary structure of insulin A-chain from
bovine and human species was previously reported by our group [24]. The insulin A-chain
is a 21-residue peptide that differs at only 2 positions for bovine and human species [25].
We used fragments of the A-chain, containing the protective group Fmoc, where those
differences are located. The peptide BIF (bovine insulin fragment) has the sequence
ASVCSLYQLENK 3

and

HIF

(human

insulin

fragment)

has

the

sequence

TSICSLYQLENK 3 . Letters in bold identify the differences in the amino acid residues in
both the fragments. At pH 1.6 and 60°C, both the fragments formed fibrils in the presence
of 1M urea and 20mM salt. Our previous work showed that temperature and ionic strength
are the most important factors during the lag phase whereas pH is more prominent during
the elongation phase during the aggregation of both fragments. We reported that the lag
times are shorter for BIF while the exponential phase rate was faster for HIF. At pH 1.6
and 60°C, the values of tlag and Kapp are 11±2 days and 0.22±0.05 day-1 for BIF and 24±2
days and 0.47±0.16 day-1 for HIF respectively whereas at 25°C, they are 12±1 days and
0.85±0.37 day-1 for BIF and 30±2 days and 0.18±0.02 day-1 for HIF respectively. In
addition, an increase in the percentage of P-sheets with time was observed in both the
fragments. Increase in P-sheets was accompanied by a simultaneous decrease in a - helices
observed during the transition from lag phase to exponential phase.
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Four peptides BIF, HIF, gBIF and gHIF are studied in this article. BIF and HIF
are the non-glycosylated peptides whereas gBIF and gHIF are their glycosylated
counterparts. To explore the effect of subtle differences in the primary structure in the
absence of Fmoc, the aggregation of pure BIF and HIF was studied at favorable fibrillation
conditions [24]. Also, to study the effect of glycosylation on the fibrillation kinetics of
insulin A-chain fragments from both bovine and human species, the peptides were further
modified using a-D-glucose. Experiments were conducted at pH 1.6, 60°C, 1M urea and
20mM NaCl both in the presence and in the absence of dithiothreitol (DTT). DTT is a
reducing reagent which can break the disulfide linkages in between peptides. We have
found that in the absence of DTT, both BIF and HIF form dimers through a disulfide
linkage. The effect of DTT on fibrillation, if any, was also explored in this work.

2. EX PER IM EN TA L SECTIO N

2.1. M A TERIA LS
Pure peptides BIF and HIF were purchased from Biobasic Inc. ThT was purchased
from Acros Organics (USA). DTT, urea, sodium chloride, Congo red dye and deuterium
oxide; 99.9 atom % D were purchased from Sigma-Aldrich (USA). All other solvents were
purchased from Fischer Scientific (USA).

2.2. G LY C O PEPTID E SYNTHESIS
The pure peptides BIF and HIF were used for the synthesis of glycopeptides gBIF
and gHIF respectively. The method used by Broersen et al. [26] was modified by increasing
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the incubation time in order to glycosylate the peptides completely. 4.83 mg of BIF or
4.96 mg of HIF and 10.53 mg of D-Glucose were added to 20 ml of DI water. The pH was
adjusted to 8. The solution was frozen at -20°C and lyophilized at -50°C. The lyophilized
powder was then transferred into a chamber which was already maintained at a relative
humidity (RH) of 65% and incubated at 60°C for 24 hours. A RH of 65% was obtained
using a saturated NaNO 2 solution. After incubation for 24 hours, the final product was
dissolved in 20 ml of DI water and then dialyzed against water for 48 hours and lyophilized
to obtain the final glycosylated peptide. The glycosylated peptides tend to dimerize upon
prolonged exposure to a humid environment. 1mM of glycosylated peptide was treated
with 10 mM DTT in 5mM ammonium acetate buffer (pH 5.5) for 30 minutes at 37°C to
break the dimers into monomers.

2.3. N M R SPEC TR O SC O PY
All the 4 peptides BIF, HIF, gBIF and gHIF were analyzed using liquid state one
dimensional (1D) 1H NMR spectroscopy. To prepare the respective peptide samples for the
analysis, 10 mg of the peptide was dissolved in 750 pl D 2 O (99.9 % deuterium). A Bruker
400-MHz spectrometer equipped with a BBO probe was used to obtain the spectra. 1H
NM R data were obtained with a sweep width of 3997.8 MHz, 0.256 s acquisition time, 16
scans and a 2s recycle delay.

2.4. MASS SPEC TR O M ETR Y
The mass of the non-glycosylated peptides BIF and HIF was obtained using a LTQ
Orbitrap. 1mg/ ml samples were diluted in 70% acetonitrile, 0.1% formic to obtain a final
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concentration of 10 pM. The sample was loaded onto a static nano spray ECONO 12 tip
(Proxeon) and analyzed using nano-electrospray ionization in positive-ion mode on a
Thermo Scientific LTQ Orbitrap XL mass spectrometer. Typical flow rates from these tips
are estimated to be 50 nL/min. FTMS data were collected in the Orbitrap (30,000 resolving
power, 100-2000 m/z, 1 micro scan, maximum inject time of 100 ms) over 2 minutes of
infusion. Xcalibur Qual Browser was used to analyze the data.
The purity and mass of the glycopeptides was determined using LC-MS. Data were
acquired on an Agilent 6520 Q-TOF LCMS system. Lyophilized glycopeptides were
suspended in 0.1% formic acid in water to obtain a final concentration of 1mg/ml. 5 pL of
the sample was loaded on an Agilent Technologies C8 protein column. An Agilent
Technologies 1200 Series Quaternary HPLC was used. The following elution protocol was
used: initial conditions 3% B (A: 0.1% formic acid in water; B: 99.9% acetonitrile, 0.1%
formic acid), rapid ramp to 50% B over 2 min, gradient 50 to 90% B over 5 min, hold at
90% B for 7 min, ramp back to (0.5 min) and hold at (2.5min) initial conditions. An Agilent
Technologies 6520A Accurate Mass QTOF MS with integrated Chip Cube source was used
to collect data. Data across a total of 15 minutes of elution were collected. MS data were
collected between 295 and 3200 m/z.

2.5. EX PER IM EN TA L DESIGN
All the experiments were carried out at pH 1.6, 60°C, 1M urea, and 20 mM NaCl
for over a span of 6 weeks initially. While the runs with the non-glycosylated peptides were
stopped after 6 weeks, the ones with the glycosylated peptides were restarted for further
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analysis. A two- level full factorial design as shown in Table 1 consisting of three factors
at two levels each with a total of 8 runs was chosen.

Table 1. Experimental design FF0308
Run

Type of
peptide

Glycosylation

DTT

Notation

1

-

-

+

BIF+

2

-

-

-

BIF-

3

-

+

+

gBIF+

4

-

+

-

gBIF-

5

+

-

+

HIF+

6

+

-

-

HIF-

7

+

+

+

gHIF+

8

+

+

-

gHIF-

Table 2. Experimental factors with low and high levels

Factor

-

+

Type of Peptide

BIF

HIF

Glycosylation

No

Yes

DTT

0

1

Type of peptide, glycosylation and DTT are the three experimental factors. The
lower and higher levels chosen for the factors are shown in Table 2.
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2.6. IN V ITR O FIB R IL LA TIO N
Samples were prepared with a peptide concentration of 10 mg/ml. All the samples
were prepared in 0.22 pm filtered phosphate buffer at pH 1.6. Urea and sodium chloride
were added at 1M and 20 mM concentrations respectively. Samples were incubated with
ThT in the presence and absence of DTT according to the experimental design at 60°C
under stirring conditions. The evolution of the fibrillation process with time was followed
by turbidity and the ThT assay. Changes in secondary structure were studied using FT-IR.
The water used for the preparation of buffers was purified to a resistivity of 17.5 MQ.cm.

2.7. TU RBID ITY ASSAY
The turbidity assay was conducted using a Thermo Spectronic Genesis 5
UV/Visible spectrophotometer. Absorbance at 600 nm was recorded for all the samples.
All the reported data were an average of 5 replicates.

2.8. TH T FLU O R ESC EN C E ASSAY
A stock solution for the ThT assay was prepared by adding 0.8 mg of ThT dye to
50 ml of 0.22 pm filtered phosphate buffer (pH 7) and stored at 4 °C in a dark place to
prevent quenching. 0.05 mM of ThT solution was added to each sample at the beginning
of incubation. Fluorescence for each sample was recorded once a week. Increase in
viscosity or the appearance of gel/ precipitate with time upon visual inspection is a
characteristic of the ThT assay [26]. All the reported fluorescence readings were an average
of 5 replicates.
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2.9. F T IR ANALYSIS
Analysis was carried out with a Nicolet 6700 FT-IR spectrometer from
Thermoscientific equipped with a KBr beam-splitter and a DTGC detector cooled by liquid
nitrogen. Samples were dried on a CaF 2 window which is used to obtain the spectra. Drying
time was kept constant from sample to sample in order to avoid any discrepancies in the
spectra. Interferograms were obtained for each sample at a resolution of 8 cm-1 and 32
scans were collected for each run to obtain a good signal-to-noise ratio.

2.10. CO NG O RED STAINING
Congo red dye was used to stain and obtain the micrographs of the fibrils. A stock
solution was prepared by adding 7 mg of Congo red to 1 ml o f 0.22 pm filtered water.
Samples containing fibrils were first centrifuged using a micro centrifuge at 9450 x g and
then washed thoroughly with water. The pellet was then resuspended in 1 ml of water and
5 pL of Congo red solution was added and incubated at 25 °C for one hour. After obtaining
a red precipitate, the sample was centrifuged again. The pellet was washed twice with water
to remove the unattached dye. The fibrils were then resuspended in a small amount of
water. 30 pL of Congo red stained fibrils were placed on a microscopic slide and air dried.
Micrographs were obtained at 1000x using Hirox KH-8700 digital microscope.
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3. R ESU LTS AND DISCUSSION

3.1. SYNTHESIS O F G LY C O PEPTID ES
The peptides bovine insulin fragment (BIF) and human insulin fragment (HIF) were
used to synthesize the glycopeptides gBIF and gHIF respectively. Mass spectrometry was
used to determine the purity of the peptides BIF and HIF. Figure 1 and 2 shows the
deconvoluted mass spectra obtained using LTQ Orbitrap.

Figure 1. Deconvoluted mass spectra for BIF
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Figure 2. Deconvoluted mass spectra for HIF

BIF and HIF were identified at masses of 1609.85 Da and 1653.88 Da with a mass
error of < 1 ppm. Both peptides have the same amino acid sequence except for two amino
acids. Each of them has two serine residues and three lysine residues which can undergo
O-glycosylation upon reacting with a-D-Glucose following the Maillard reaction [27].
Both glycosylated peptides were analyzed using a C8 column on a 1200 series LC attached
to an Agilent Technologies 6520A QTOF mass spectrometer. Figures 3 and 4 shows the
chromatograms for both gBIF and gHIF respectively. The samples were well resolved with
a major peak around 14 min.
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Figure 3. Chromatograms showing the elution of gBIF at around 14 min

Figure 4. Chromatograms showing the elution of gHIF at around 14 min
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Figure 5. Deconvoluted mass spectra for gBIF

Figure 6. Deconvoluted mass spectra for gBIF
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Deconvoluted mass spectra for gBIF and gHIF are shown in Figures 5 and 6
respectively. The peptide gBIF is 93% glycosylated whereas gHIF is fully glycosylated.
About 86% of gBIF has 1-3 glucoses attached to the peptide with an average mass of
1934.62 Da and 87% of gHIF has 2-4 glucoses attached to the peptide with an average
mass of 2141.04 Da while rest of the 13% has 5 glucoses attached. About 7% of gBIF is
non-glycosylated monomer and rest of the 7% has 4 glucoses.

Figure 7. Full 1H NM R spectra showing the comparison of BIF and HIF

3.2. N M R ANALYSIS
To determine the amino acid composition and to confirm the glucose attachment to
the peptides, 1H NM R spectroscopy was carried out on all the four peptides. Based on the
proton chemical shifts for each amino acid, the 1H resonance assignments were done.
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Standards for the proton chemical shifts were taken from the Biological Magnetic
Resonance Data Bank [28]. 1H NMR spectra for the side chain, back bone and aromatic
regions are shown separately along with the full spectra for better understanding. A
comparison of the full spectra is shown in Figure 7 for BIF and HIF which shows clearly
that there are only subtle differences in the spectra.

Figure 8. 1H NM R spectra showing the comparison of BIF and HIF for back bone,
side chain and aromatic regions
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Figure 9. NM R spectra showing the attachment of glucose in BIF

Figure 10. NM R spectra showing the attachment of glucose in HIF
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These subtle differences are highlighted in Figure 8 which shows the backbone
region, side chain and aromatic region in an expanded view. Assignments for rest all the
amino acids were discussed in detail in our previous work [24].

Figure 11. Comparison o f various regions for glycosylated and non-glycosylated
peptides in BIF

Figures 9 and 10 shows the comparison of gBIF and gHIF with its respective nonglycosylated counterparts in the backbone region. The peaks between 3- 3.75 ppm and at
around 5 ppm (highlighted in black dotted line) are evident only in gBIF and gHIF which
are absent in BIF and HIF. These peaks correspond to the presence of glucose attachment
in the glycosylated peptides [29]. Also, the peaks at around 4.5 ppm (highlighted in blue
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dotted line) correspond to lysine and serine which has higher intensity in the
glycosylated ones as compared to the non-glycosylated ones. Lysine and serine being the
glycosylation sites and the attachment of glucose to these amino acids could have resulted
in higher intensity [30].

Figure 12. Comparison o f various regions for glycosylated and non-glycosylated
peptides in HIF

A comparison of the side chains and aromatic regions is shown for gBIF and gHIF
in Figures 11 and 12 respectively. All other peaks except for the peaks around 1.75 ppm
and 8.25 ppm show an increase in the intensity in the glycosylated ones. These peaks
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correspond to Lys Hp and Ser Hi respectively. This clearly shows that both the peptides
BIF and HIF are glycosylated at Lys and Ser residues to form gBIF and gHIF respectively.

3.3. K IN E T IC STUDIES USING D IFFER EN T ASSAYS
The formation of fibrils can follow different kinetic pathways. Different assays are
used to track the progress of fibril formation with time. Popular among them are the ThT
and the turbidity assays. Fluorescence can be monitored in the presence of a ThT dye at an
emission wavelength of 485 nm whereas turbidity can be monitored by measuring the
absorbance at 600 nm [30,31]. ThT dye binds to amyloid fibrils. Thus, it can only track the
fibrillation once the fibrils start to form. It cannot monitor the process during the pre
fibrillar stage where monomers convert into globular oligomers.
This can be monitored using crystal violet dye which has a strong absorbance at
590 nm and is a strong oligomer selective dye [33,34]. The use of a particular method may
hinder the true kinetics. For example, fibril formation monitored using ThT dye follows
sigmoidal kinetics. On the contrary, by using crystal violet dye monitoring a biphasic
kinetic pathway was observed [33]. This biphasic behavior corresponds to the presence of
a secondary nucleation mechanism on top of the primary nucleation where fibrils undergo
further oligomerization. Globular oligomers formed in the initial lag phase of 2-step
kinetics elongate into curvilinear fibrils in the primary nucleation step. These curvilinear
fibrils upon further oligomerization convert into rigid fibrils in the secondary nucleation
step.
All the non-glycosylated peptides formed fibrils over a span of six weeks.
Nevertheless, the glycosylated peptides were still in the lag phase both in the presence and
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absence of DTT. Figure 13 shows the turbidity plots (absorbance at 600 nm vs time in
days) and fittings for BIF+, BIF-, HIF+ and HIF- along with its glycosylated counterparts.
A similar biphasic kinetics was observed in our experimental data which can be fit using
the following model [34].

1-p
p_____
J = A1 + (A2 - A1) [_____
1 +1 0 (logxoi-x)fci + 1+10(l°gxo2-x)k2

where A1 = 0, A2 = 1, p =0.5 which leaves us with four parameters to fit the data.

Figure 13. Turbidity plots along with its respective fits for each peptide

(1)
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Table 3. Lag time and aggregation growth rate constant for all the runs
Run#

Notation

tlag1 (days)

tlag2 (days)

K 1 (day-1)

K 2 (day-1)

1

BIF+

15±1

16±1

0.09±0.03

0.59±0.22

2

BIF-

12±1

14±1

0.27±0.05

0.69±0.01

3

gBIF+

-

-

-

-

4

gBIF-

-

-

-

-

5

HIF+

11±1

4±2

0.65±0.27

0.08±0.01

6

HIF-

10±1

2±1

0.59±0.05

0.09±0.01

7

gHIF+

-

-

-

-

8

gHIF-

-

-

-

-

The parameters k 1 and k 2 correspond to the growth rate constants and log x01 = tlag1
and log x02 = tlag2 . k 1 and tlag1 are the growth rate and the lag phase for the conversion of
globular oligomers into curvilinear fibrils while k 2 and tlag2 are the growth rate and the lag
phase for the conversion of curvilinear fibrils into rigid fibrils. The details of all the runs
in our experimental design are shown in Tables 1 and 2 along with its detailed notations.
The prefix ‘g ’ to any peptide refers to its glycosylated counterpart and the suffix ‘+ ’
indicates the presence of DTT and ‘-‘ the absence of DTT.
The fitted parameters (tlag1 , tlag2 , k 1 , and k 2 ) are reported in Table 3. For the
conversion of oligomers to curvilinear fibrils the lag times (tlag1) for HIF+, HIF- and BIF
are an average of 11 days whereas it is slower for BIF+ at 15 days. In both the fragments
tlag1 is faster in the absence o f DTT (BIF- and HIF-) in comparison with those in the
presence of DTT (BIF+ and HIF+). Because the peptides remain monomeric in the
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presence of DTT but they are dimers in its absence we can conclude that dimers
aggregate faster than monomers. The rate of conversion of oligomers to curvilinear fibrils
(k 1) is faster for human fragments in both the runs than their respective bovine fragments.

-BIF-Turbidity
p -- — -

-BIF-ThT

-B

-

j J
-

1500

if

-

1000

3

>
w

5

10

15

20

25

30

35

40

45

50

10

.a ___a - -O''1

15

Time {Days)

u

ft

'd

20

25

30

35

40

45

50

Time {Days)

- HIF-Turbidity

Absorbance

Relative Fluorescence

- HIF-ThT

10

15

20

25

30

Time (Days)

35

40

45

50

--- ---- ---- ---- ---- ---- ---- --

I----------- 1

1

1

1

1

1

1

1

5

15

20

25

30

35

40

45

10

50

Time (Days)

Figure 14. Turbidity and ThT plots comparison for each peptide

This is opposite for the rate of conversion of curvilinear fibrils into rigid fibrils (k 2 ).
The value of k 2 is higher for BIF+ and BIF- in comparison with HIF+ and HIF-. But the
lag time (tlag2 ) for the formation of rigid fibrils from curvilinear fibrils is shorter for human
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fragments and in case of bovine fragments tiag2 is even longer than tiagi. Although, a
clear 2-step mechanism is not evident for HIF-, the data fits well with the biphasic model.

Table 4. Lag time and aggregation growth rate constant for non-glycosylated peptides
using ThT assay
Run#

Notation

tlag (days)

Kapp (day-1)

1

BIF+

23±1

0.53±0.03

2

BIF-

22±1

0.41±0.05

5

HIF+

16±1

0.62±0.07

6

HIF-

15±1

0.87±0.05

A similar analysis was

conducted using ThT data. We observed a sigmoidal

kinetics as opposed to biphasic kinetics which clearly shows that ThT assay cannot
distinguish between oligomer intermediates and rigid fibrils. The two datasets for each
peptide are compared in Figure 14. It clearly shows a sigmoidal kinetics with ThT assay
and a biphasic kinetics with the turbidity assay. The data obtained using ThT assay were
analyzed and fit using the model described in our previous work [24]. The values for tlag
and kapp obtained using the model were tabulated in Table 4. The lag times are 23±1 days
and 22±1 days for BIF+ and BIF- respectively while they are 16±1 days and 15±1 days for
HIF+ and HIF- respectively. In the absence of DTT at pH 1.6 and 60°C, these values can
be compared with those from our previous work for Fmoc-BIF and Fmoc-HIF. The lag
time for BIF is longer in comparison with Fmoc-BIF (11±2 days) while for HIF it is shorter
in comparison with Fmoc-HIF (24±2 days). Also, the growth rate constants for both BIF
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(0.41±0.05 day-1) and HIF (0.87±0.05 day-1) are faster in comparison with Fmoc-BIF
(0.22±0.05 day-1) and Fmoc-HIF (0.47±0.16 day-1) respectively.

3.4. SEED IN G EX PER IM EN TS
The fibril samples BIF- and HIF- at the end of experiment are used to further
conduct seeding experiments. A fresh 10 mg/ml of the respective peptide sample was added
to the existing fibrillar sample and monitored using turbidity. These fibrils act as seeds to
the monomers added which can accelerate the process of fibrillation.

Figure 15. Turbidity plots comparison for each peptide in seeding experiments
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Figure 15 shows the turbidity plots along with its respective fits using biphasic
model for BIF' and HIF' respectively. The lag time tlag1 is shorter for BIF' in comparison
with HIF' while it is the opposite for tlag2 . Similarly, the rate constant k 1 is faster and k 2 is
slower for BIF'.

Figure 16. FTIR spectra showing the amide I peaks and their corresponding
deconvoluted spectra for BIF and HIF in the absence of DTT
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3.5. SECONDARY STRU CTU RE ANALYSIS
Another important characteristic of an amyloid fibril is the formation of
intermolecular P-sheets [26]. Secondary structure of a protein can be monitored using
Fourier Transform Infrared spectroscopy (FTIR). The amide I peak obtained using an FTIR
ranges between 1700-1600 cm-1. With change in the secondary structure of a
protein/peptide the amide I peak shifts its position [36]. Second derivative analysis of the
spectra deconvolutes the band to highlight the underlying peaks which corresponds to
specific secondary structure [37,38] which can be used to characterize both oligomers (anti
parallel P-sheets) and amyloid fibrils (parallel P-sheets).
Figure 16 shows the comparison of amide I peaks (top panel) along with its
deconvoluted spectra (bottom panel) for BIF and HIF in the absence of DTT. The amide I
spectra are shown at three different stages of the fibril formation as mentioned above i.e.,
during the initial stage when the peptides are monomers or dimers, during the conversion
of oligomers to curvilinear fibrils and then during the conversion of curvilinear fibrils to
rigid fibrils. A clear shift in the amide I peak with the progress of fibril formation can be
seen in Figure 16 for both the peptides. From the second derivative spectra, during the
initial stage both the peptides BIF and HIF in the absence of DTT show prominent peaks
at around 1630, 1660 and 1680 cm-1 respectively which correspond to native P-sheets, a helices and turns. During the transition of oligomers to curvilinear fibrils, the peak at 1630
cm-1 shifts to around 1618 cm-1 in BIF which is an indicative o f amyloid fibrils. But in HIF,
a peak at 1630 cm-1 still persists along with the peak at 1618 cm-1, which indicates some
amount of native P-sheets. In addition, an intermediate increase in the peak at 1660 cm-1
indicates the presence of increase in a-helices in both the peptides as evident from Figure
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16 (bottom panel). During the final stage of Curvilinear fibril/ Rigid fibril transition,
only amyloid fibrils are present in both the peptides while the peak at 1660 cm-1 which
corresponds to a-helices decreases at the expense of random coils and turns in both the
peptides. Although the glycosylated peptides are still in the lag phase after six weeks, there
are some changes in the secondary structure as shown in Figure 17. A plot of amide I peak
and their respective deconvoluted spectra at three different times are shown in Figure 17
for both gBIF and gHIF respectively.

Figure 17. FTIR spectra showing the amide I peaks and their corresponding
deconvoluted spectra for gBIF and gHIF in the absence of DTT
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At t=0 days, both the glycopeptides are rich in a-helices, random coils and turns
while at t=14 days both the peptides show increase in a-helices with a small peak at around
1620 cm-1. At t=28 days, a peak at around 1635 cm-1 is prominent which corresponds to
parallel P-sheets along with a peak around 1690 cm-1 which corresponds to anti-parallel Psheets which shows that the glycosylated peptides are still in oligomer phase. After 28
days, no change in the amide I peak was observed for both gBIF and gHIF; therefore, they
stay as oligomers.
A similar analysis was also conducted on all the four peptides in the presence of
DTT. Figure18 shows the deconvoluted amide I peaks at different stages for BIF+, HIF+,
gBIF+ and gHIF+ respectively. BIF and gBIF show transitions in its secondary structure
similar to those observed in the absence of DTT. This is not true in case of HIF and gHIF.
For HIF in the presence of DTT, the intensity of peak at 1620 cm-1 decreased as it reaches
final aggregation stage with a prominent peak close to 1640 cm-1; this suggests that HIF+
is rich in parallel P-sheets but not in fibrils.
The effect of DTT on both the peptides BIF and HIF can be explained as follows.
For HIF in the presence of DTT, there is no significant shift in the peak around 1620 cm-1
during the curvilinear fibril/rigid fibril transition. Hence in both the peptides, absence of
DTT favors the formation of rigid fibrils while its presence slows down the process
resulting in only curvilinear fibrils for HIF.
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Figure 18. FTIR spectra showing the corresponding deconvoluted spectra for BIF and
HIF in the presence of DTT

3.6. CO NG O RED ANALYSIS
It is well known that Congo red binds to amyloid fibrils [41]. Free Congo red shows
a peak maxima at around 500 nm while Congo red bound to the fibrils shows a peak shift
to around 540 nm [42]. The fibrils obtained at the end of experiment were suspended in
water and incubated with Congo red for 1 hr. Wavelength scans from 400 to 700 nm were
done immediately after the dye was added and after 1 hr has elapsed. Figures 19 and 20
show a wavelength scan of fibrils between 400 - 700 nm for BIF and HIF respectively both
in the presence and absence of DTT.
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Figure 19. Congo Red spectroscopy revealing the shift in the peak for BIF at different
conditions

Before the incubation starts, a peak at around 500 nm is persistent in all the four
samples (BIF+, BIF-, HIF+ and HIF-), that corresponds to the free dye. After 1 hour, a shift
in the peak maxima and an increase in the absorbance is observed in all the samples which
corresponds to the presence of fibrils. Microscopy was used to provide a visual
confirmation of the presence of fibrils. Staining the samples with Congo red dye and
inspection under a digital microscope shows the morphology of both the fibrils formed by
peptides BIF and HIF both in the presence and absence of DTT (Figures 23-26). All the
micrographs were obtained at a magnification of 1000x.
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Figure 21. Micrographs showing the presence of fibrils for BIF+
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Figure 22. Micrographs showing the presence of fibrils for BIF in absence of DTT

Figure 23. Micrographs showing the presence of fibrils for HIF+
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Figure 24. Micrographs showing the presence of fibrils for HIF in absence of DTT

Figures 21 and 22 show the Congo red stained fibrils for BIF+ and BIF- whereas
Figures 23 and 24 shows the fibrils for HIF+ and HIF-. Annular amyloid aggregates are
observed in all of the samples which is an indication of amyloidosis but denser fibrillar
structures are observed in the absence of DTT (Figure 22 and 24) which is not seen in its
presence (Figure 21 and 23).

4. CONCLUSIONS

Two bovine and human insulin A-chain fragments (BIF and HIF) were successfully
glycosylated using a-D-glucose. Using LC-MS and 1H NMR, the attachment of the sugar
to the peptide was confirmed. Delay in the kinetics of fibrillation was observed in the
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glycosylated peptides in comparison with their non-glycosylated counterparts. We
found a biphasic kinetics for both BIF and HIF in the presence and absence of DTT, which
was not observed previously using the ThT assay. A progression in fibril formation from
monomer to globular oligomers to curvilinear fibrils to rigid fibrils was observed for both
peptides. Changes in the secondary structure of both peptides were observed during
fibrillation. Both BIF and HIF show prominent peaks corresponding to amyloid fibrils
(1620 cm-1) while the glycosylated peptides have aggregates still in the pre-fibrillar stage.
Congo red stained fibrils further confirm the presence of fibrils both in the presence and
absence of DTT.
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SECTIO N

2. CONCLUSIONS AND FU TURE W O R K

2.1. CONCLUSIONS
Protein stability is of great concern not only to sustain life but also for the
biopharmaceutical business, which uses live organisms to make protein-based therapeutics
and vaccines. This dissertation is a humble effort to better understand and control protein
stability. We recognize that the lack o f stability may translate into different phenomena
ranging from protein aggregation to loss of biological activity caused by subtle changes in
the protein’s three-dimensional shape. Because of that, our studies ranged from
experiments probing molecular level phenomena to experiments at the macroscopic scale.
The molecule that we selected for the molecular level experiments was human serum
albumin (HSA) because it is abundant, cheap, and well characterized. The molecule(s)
chosen for the macroscopic-scale experiments were the amylogenic regions of bovine and
human insulin. That choice was our attempt to prove the universality of the aggregation
process as well as testing means to inhibit it. The molecular level experiments consisted of
using SANS to detect changes in structure and in the intermolecular forces of HSA
molecules as the environment was changed from physiological conditions to situations of
stress. The macroscopic experiments consisted of inducing the formation of aggregates for
the two fragments and monitoring the kinetics of aggregation using various experimental
techniques. In the following paragraphs, the main conclusions of the three chapters of this
dissertation are discussed in more detail.
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In Paper I, the effect of cosolvents, pH and temperature on HSA conformation
and protein-protein interactions was explored using SANS. The shape of HSA changed
from a prolate to an oblate ellipsoid in the absence of intermolecular interactions with an
increase in protein concentration. The addition methanol and glycerol affected the strength
and range of intermolecular interactions. Methanol makes the solution of HSA more gas
like (disordered) whereas the addition of glycerol makes the solution more liquid-like
(ordered). The effect of temperature on the intermolecular potential was negligible.
In Paper II, two peptide fragments o f insulin A-chain with subtle differences in their
primary structure were synthesized and their fibrillation propensity was studied using
fluorescence and infrared spectroscopy. The presence of an Fmoc group attached to the
peptide has an impact on the fibrillation kinetics, which is dependent on pH and
temperature. We found that in the presence of Fmoc, the bovine insulin fragments have a
shorter lag time than the human insulin ones but, for most samples, the exponential phase
rate was faster for HIF than for BIF. An increase in P-sheets content with time was observed
in both fragments. The conversion of oligomer structures rich in anti-parallel P-sheets to
fibrils rich in parallel P-sheets is a characteristic o f amyloid formation.
In Paper III, the fragments of insulin A-chain BIF and HIF were successfully
glycosylated using a-D-glucose. The glycosylated peptides (gBIF and gHIF) were highly
stable and they did not show signs of fibril formation during the course of the experiment.
Some changes in the secondary structure were observed. In the absence of Fmoc, HIF has
a shorter lag time than BIF. Turbidity measurements showed a relatively more complex
kinetic than ThT measurements. A two phases kinetics was observed in the presence and
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absence of DTT. A clear progress in the fibril formation from monomer to globular
oligomers to curvilinear fibrils and finally rigid fibrils was observed in both the peptides.

2.2. FU TURE W O R K
Several questions were answered in this dissertation but an equal number has arose
as a consequence of this work. A better characterization of the intermediates formed during
the aggregation process as well as other means of inhibiting the formation of fibrils are
worth to be pursued. The use of a P-sheet specific dye like ThT or Congo Red helped in
monitoring the kinetics of fibril formation but they do not provide the same insight into the
process as oligomer-specific assays. Also, visual monitoring of the aggregates in real time
would advance the understanding of the fibril formation process. Finally, a better
quantification of the sizes and shape of these aggregates is needed to better understand the
difference between amorphous and amyloid aggregates.
Techniques like Nano IR spectroscopy, flow cytometry, multiple angle light
scattering (MALS) and X-ray diffraction (XRD) help in differentiating amyloid aggregates
from amorphous ones. Nano IR, a combination of atomic force microscopy and infra-red
spectroscopy can help in analyzing the type of aggregates in real time [37]. Flow cytometry
can characterize protein aggregates of different size and composition. A MALS instrument
coupled with HPLC system can determine absolute molar mass, size and shape of the
aggregates directly [38]. Finally, XRD in combination with solid state NM R can help in
identifying the atomic resolution structures of amyloid fibrils [39,40].
Our results showed that glycopeptides of both insulin fragments typically had 2-4
sugars attached to the peptide. Glycopeptides seem to be stable but the effect of the number
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of carbohydrate moieties on each peptide was not explored. Moreover, the type of sugar
and the type of anomeric configuration of each sugar have a potential impact on the fibril
formation kinetics. Exploring these factors with a comprehensive experimental design in
combination with selective glycosylation of the peptides along with the use of the new
techniques mentioned in the previous paragraph can take the study to a whole new level
and make substantial progress in the control of protein aggregation.
Phosphorylation and lipidation are other important posttranslational modifications
that can effect amyloidogenesis. Phosphorylation consists of the addition of phosphoryl
groups to the serine amino acid during peptide synthesis and lipidation consists of the
attachment of aliphatic hydrocarbons typically on a cysteine residue. Literature shows that
phosphorylation [41,42] and lipidation [43] can affect the molecular stability of P-amyloid
deposits. Exploring these two posttranslational modifications along with glycosylation
would have an impact in the understanding (and prevention) of amyloidogenesis at a
molecular level.

134
BIB LIO G R A PH Y

(1)

Deller, M. C.; Kong, L.; Rupp, B. Protein Stability: A Crystallographer’s
Perspective.
Acta
Crystallographica
Section:F
Structural
Biology
Communications. International Union of Crystallography 2016, pp 72-95.

(2)

Gromiha, M. M. Protein Stability. In Protein Bioinformatics; Elsevier, 2010; pp
209-245.

(3)

Nick Pace, C.; Scholtz, J. M.; Grimsley, G. R. Forces Stabilizing Proteins. FEBS
Lett. 2014, 588 (14), 2177-2184.

(4)

Lesser, G. J.; Rose, G. D. Hydrophobicity of Amino Acid Subgroups in Proteins.
Proteins Struct. Funct. Bioinforma. 1990, 8 (1), 6-13.

(5)

Myers, J. K.; Pace, C. N. Hydrogen Bonding Stabilizes Globular Proteins. Biophys.
J. 1996, 71 (4), 2033-2039.

(6)

Dombkowski, A. A.; Sultana, K. Z.; Craig, D. B. Protein Disulfide Engineering.
FEBS Letters. No longer published by Elsevier January 21, 2014, pp 206-212.

(7)

Li, R.; Wu, Z.; Wangb, Y.; Ding, L.; Wang, Y. Role of PH-Induced Structural
Change in Protein Aggregation in Foam Fractionation of Bovine Serum Albumin.
Biotechnol. Reports 2016, 9, 46-52.

(8)

Thomas, T.; Cavicchioli, R. Effect of Temperature on Stability and Activity of
Elongation Factor 2 Proteins from Antarctic and Thermophilic Methanogens. J.
Bacteriol. 2000, 182 (5), 1328-1332.

(9)

Przybycien, T. M.; Bailey, J. E. Secondary Structure Perturbations in Salt-Induced
Protein Precipitates. Biochim. Biophys. Acta 1991, 1076 (1), 103-111.

(10)

Allen, S. J.; Schwartz, A. M.; Bush, M. F. Effects of Polarity on the Structures and
Charge States of Native-like Proteins and Protein Complexes in the Gas Phase.
Anal. Chem. 2013, 85 (24), 12055-12061.

(11)

Gonnelli, M.; Strambini, G. B. Glycerol Effects on Protein Flexibility: A
Tryptophan Phosphorescence Study. Biophys. J. 1993, 65 (1), 131-137.

(12)

Canchi, D. R.; Garcia, A. E. Cosolvent Effects on Protein Stability. Annu. Rev.
Phys. Chem. 2013, 64 (1), 273-293.

135
(13)

Patel, R.; Kumari, M.; Khan, A. B. Recent Advances in the Applications of
Ionic Liquids in Protein Stability and Activity: A Review. Applied Biochemistry
and Biotechnology. Humana Press Inc. March 6, 2014, pp 3701-3720.

(14)

Gordon, C. M. New Developments in Catalysis Using Ionic Liquids. Appl. Catal.
A Gen. 2001, 222 (1-2), 101-117.

(15)

Satish, L.; Millan, S.; Sahoo, H. Sustained Activity and Stability of Lysozyme in
Aqueous Ionic Liquid Solutions Containing Carboxymethylcellulose and
Polyethylene Glycol. J. Mol. Liq. 2019, 278, 329-334.

(16)

Azuaga, A. I.; Dobson, C. M.; Mateo, P. L.; Conejero-Lara, F. Unfolding and
Aggregation during the Thermal Denaturation of Streptokinase. Eur. J. Biochem.
2002, 269 (16), 4121-4133.

(17)

Dong, A.; Prestrelski, S. J.; Allison, S. D.; Carpenter, J. F. Infrared Spectroscopic
Studies of Lyophilization- and Temperature-induced Protein Aggregation. J.
Pharm. Sci. 1995, 84 (4), 415-424.

(18)

Pace, C. N.; Grimsley, G. R.; Scholtz, J. M. Protein Ionizable Groups: PK Values
and Their Contribution to Protein Stability and Solubility. Journal of Biological
Chemistry. American Society for Biochemistry and Molecular Biology May 15,
2009, pp 13285-13289.

(19)

Anderson, D. E.; Becktel, W. J.; Dahlquist, F. W. PH-Induced Denaturation of
Proteins: A Single Salt Bridge Contributes 3-5 Kcal/Mol to the Free Energy of
Folding of T4 Lysozyme. Biochemistry 1990, 29 (9), 2403-2408.

(20)

de Groot, N. S.; Sabate, R.; Ventura, S. Amyloids in Bacterial Inclusion Bodies.
Trends Biochem. Sci. 2009, 34 (8), 408-416.

(21)

Galzitskaya, O. V; Galushko, E. I.; Selivanova, O. M. Studies of the Process of
Amyloid Formation by Ap Peptide. Biochem. 2018, 83 (S1), S62-S80.

(22)

Selivanova, O. M.; Surin, A. K.; Marchenkov, V. V.; Dzhus, U. F.; Grigorashvili,
E. I.; Suvorina, M. Y.; Glyakina, A. V.; Dovidchenko, N. V.; Galzitskaya, O. V.
The Mechanism Underlying Amyloid Polymorphism Is Opened for Alzheimer’s
Disease Amyloid-P Peptide. J. Alzheimer’s Dis. 2016, 54 (2), 821-830.

(23)

Galzitskaya, O. V.; Selivanova, O. M. Rosetta Stone for Amyloid Fibrils: The Key
Role of Ring-Like Oligomers in Amyloidogenesis. J. Alzheimer’s Dis. 2017, 59
(3), 785-795.

136
(24)

Selivanova, O. M.; Glyakina, A. V.; Gorbunova, E. Y.; Mustaeva, L. G.;
Suvorina, M. Y.; Grigorashvili, E. I.; Nikulin, A. D.; Dovidchenko, N. V.; Rekstina,
V. V.; Kalebina, T. S.; Surin, A. K.; Galzitskaya, O. V. Structural Model of
Amyloid Fibrils for Amyloidogenic Peptide from Bgl2p-Glucantransferase of S.
Cerevisiae Cell Wall and Its Modifying Analog. New Morphology of Amyloid
Fibrils. Biochim. Biophys. Acta - Proteins Proteomics 2016, 1864 (11), 1489-1499.

(25)

Selivanova, O. M.; Surin, A. K.; Ryzhykau, Y. L.; Glyakina, A. V.; Suvorina, M.
Y.; Kuklin, A. I.; Rogachevsky, V. V.; Galzitskaya, O. V. To Be Fibrils or to Be
Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of
Fragments o f Ap Peptide. Langmuir 2018, 34 (6), 2332-2343.

(26)

McBride, S. A.; Sanford, S. P.; Lopez, J. M.; Hirsa, A. H. Shear-Induced Amyloid
Fibrillization: The Role of Inertia. Soft Matter 2016, 12 (14), 3461-3467.

(27)

Vaquer-Alicea, J.; Diamond, M. I. Propagation of Protein Aggregation in
Neurodegenerative Diseases. Annu. Rev. Biochem. 2019, 88 (1), 785-810.

(28)

Fandrich, M.; Fletcher, M. A.; Dobson, C. M. Amyloid Fibrils from Muscle
Myoglobin. Nature 2001, 410 (6825), 165-166.

(29)

Maji, S. K.; Perrin, M. H.; Sawaya, M. R.; Jessberger, S.; Vadodaria, K.; Rissman,
R. A.; Singru, P. S.; Nilsson, K. P. R.; Simon, R.; Schubert, D.; Eisenberg, D.;
Rivier, J.; Sawchenko, P.; Vale, W.; Riek, R. Functional Amyloids as Natural
Storage of Peptide Hormones in Pituitary Secretory Granules. Science 2009, 325
(5938), 328-332.

(30)

Bermudez, O.; Forciniti, D. Aggregation and Denaturation of Antibodies: A
Capillary Electrophoresis, Dynamic Light Scattering, and Aqueous Two-Phase
Partitioning Study. In Journal of Chromatography B: Analytical Technologies in
the Biomedical and Life Sciences; 2004; Vol. 807, pp 17-24.

(31)

Png, G. M.; Falconer, R. J.; Abbott, D. Tracking Aggregation and Fibrillation of
Globular Proteins Using Terahertz and Far-Infrared Spectroscopies. IEEE Trans.
Terahertz Sci. Technol. 2016, 6 (1), 45-53.

(32)

Krebs, M. R. .; Wilkins, D. K.; Chung, E. W.; Pitkeathly, M. C.; Chamberlain, A.
K.; Zurdo, J.; Robinson, C. V; Dobson, C. M. Formation and Seeding of Amyloid
Fibrils from Wild-Type Hen Lysozyme and a Peptide Fragment from the PDomain. J. Mol. Biol. 2000, 300 (3), 541-549.

(33)

Shental-Bechor, D.; Levy, Y. Folding of Glycoproteins: Toward Understanding the
Biophysics of the Glycosylation Code. Current Opinion in Structural Biology.
October 2009, pp 524-533.

137
(34)

Hu, J.; Guo, Y.; Li, Y. Research Progress in Protein Post-Translational
Modification. Chinese Sci. Bull. 2006, 51 (6), 633-645.

(35)

Ogasawara, M.; Katsumata, T.; Egi, M. Taste Properties of Maillard-Reaction
Products Prepared from 1000 to 5000 Da Peptide. Food Chem. 2006, 99 (3), 600
604.

(36)

Cudic, M.; Ertl, H. C. J.; Otvos, L. Synthesis, Conformation and T-Helper Cell
Stimulation of an O-Linked Glycopeptide Epitope Containing Extended
Carbohydrate Side-Chains. Bioorganic Med. Chem. 2002, 10 (12), 3859-3870.

(37)

Ruggeri, F. S.; Longo, G.; Faggiano, S.; Lipiec, E.; Pastore, A.; Dietler, G. Infrared
Nanospectroscopy Characterization of Oligomeric and Fibrillar Aggregates during
Amyloid Formation. Nat. Commun. 2015, 6, 7831.

(38)

Gentiluomo, L.; Schneider, V.; Roessner, D.; FrieB, W. Coupling Multi-Angle
Light Scattering to Reverse-Phase Ultra-High-Pressure Chromatography (RPUPLC-MALS) for the Characterization Monoclonal Antibodies. Sci. Rep. 2019, 9
(1), 1-8.

(39)

Nielsen, J. T.; Bjerring, M.; Jeppesen, M. D.; Pedersen, R. O.; Pedersen, J. M.;
Hein, K. L.; Vosegaard, T.; Skrydstrup, T.; Otzen, D. E.; Nielsen, N. C. Unique
Identification of Supramolecular Structures in Amyloid Fibrils by Solid-State NMR
Spectroscopy. Angew. Chemie - Int. Ed. 2009, 48 (12), 2118-2121.

(40)

Morris, K. L.; Serpell, L. C. X-Ray Fibre Diffraction Studies of Amyloid Fibrils.
Methods Mol. Biol. 2012, 849, 121-135.

(41)

Liang, F. C.; Chen, R. P. Y.; Lin, C. C.; Huang, K. T.; Chan, S. I. Tuning the
Conformation Properties of a Peptide by Glycosylation and Phosphorylation.
Biochem. Biophys. Res. Commun. 2006, 342 (2), 482-488.

(42)

Rezaei-Ghaleh, N.; Amininasab, M.; Kumar, S.; Walter, J.; Zweckstetter, M.
Phosphorylation Modifies the Molecular Stability of P-Amyloid Deposits. Nat.
Commun. 2016, 7 (1), 1-9.

(43)

Dal Magro, R.; Simonelli, S.; Cox, A.; Formicola, B.; Corti, R.; Cassina, V.; Nardo,
L.; Mantegazza, F.; Salerno, D.; Grasso, G.; Deriu, M. A.; Danani, A.; Calabresi,
L.; Re, F. The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects
the P-Amyloid Efflux Across the Blood-Brain Barrier in Vitro. Front. Neurosci.
2019, 13 (MAY), 419.

138
VITA

Paul Praveen Nakka was born in Tenali, Andhra Pradesh, India. In 2009, Paul
relocated to Hyderabad, India to complete his bachelor’s degree in chemical engineering.
Upon securing his bachelor’s degree in 2013, Paul decided to expand his knowledge and
acquire skills to conduct his own research. He moved to United States in 2014 and got
admitted into Missouri University of Science and Technology, Rolla, MO. He pursued his
doctoral studies in the department of Chemical Engineering under Dr. Daniel Forciniti and
obtained his PhD in Chemical Engineering in August 2020.

